NZ754023A - Nasal mask system - Google Patents
Nasal mask system Download PDFInfo
- Publication number
- NZ754023A NZ754023A NZ754023A NZ75402312A NZ754023A NZ 754023 A NZ754023 A NZ 754023A NZ 754023 A NZ754023 A NZ 754023A NZ 75402312 A NZ75402312 A NZ 75402312A NZ 754023 A NZ754023 A NZ 754023A
- Authority
- NZ
- New Zealand
- Prior art keywords
- region
- nose
- patient
- nasal
- sealing
- Prior art date
Links
- 210000001331 nose Anatomy 0.000 claims abstract description 259
- 238000007789 sealing Methods 0.000 claims abstract description 193
- 239000012528 membrane Substances 0.000 claims abstract description 73
- NOQGZXFMHARMLW-UHFFFAOYSA-N Daminozide Chemical compound CN(C)NC(=O)CCC(O)=O NOQGZXFMHARMLW-UHFFFAOYSA-N 0.000 claims abstract description 35
- 210000000537 nasal bone Anatomy 0.000 claims abstract description 20
- 210000002184 nasal cartilage Anatomy 0.000 claims abstract description 13
- 239000002356 single layer Substances 0.000 claims abstract description 7
- 210000000845 cartilage Anatomy 0.000 claims description 26
- 230000029058 respiratory gaseous exchange Effects 0.000 claims description 14
- 230000006835 compression Effects 0.000 claims description 10
- 238000007906 compression Methods 0.000 claims description 10
- 238000005516 engineering process Methods 0.000 description 147
- 210000000088 lip Anatomy 0.000 description 85
- 239000003570 air Substances 0.000 description 62
- 210000003128 head Anatomy 0.000 description 22
- 230000003019 stabilising effect Effects 0.000 description 22
- 238000000034 method Methods 0.000 description 21
- 239000007789 gas Substances 0.000 description 18
- 210000000988 bone and bone Anatomy 0.000 description 15
- 239000000463 material Substances 0.000 description 15
- 210000005069 ears Anatomy 0.000 description 12
- 210000002050 maxilla Anatomy 0.000 description 12
- 210000003928 nasal cavity Anatomy 0.000 description 12
- 208000023504 respiratory system disease Diseases 0.000 description 12
- 229920002379 silicone rubber Polymers 0.000 description 12
- 210000001061 forehead Anatomy 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 9
- 210000003205 muscle Anatomy 0.000 description 9
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 8
- 241000083547 Columella Species 0.000 description 8
- 230000000241 respiratory effect Effects 0.000 description 8
- 230000007958 sleep Effects 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 210000004373 mandible Anatomy 0.000 description 7
- 208000018360 neuromuscular disease Diseases 0.000 description 7
- 229920001296 polysiloxane Polymers 0.000 description 7
- 210000003484 anatomy Anatomy 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- 208000035475 disorder Diseases 0.000 description 6
- 230000001815 facial effect Effects 0.000 description 6
- 210000000103 occipital bone Anatomy 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 239000001301 oxygen Substances 0.000 description 6
- 210000003800 pharynx Anatomy 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 5
- 239000004944 Liquid Silicone Rubber Substances 0.000 description 5
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 5
- 238000005452 bending Methods 0.000 description 5
- 210000003123 bronchiole Anatomy 0.000 description 5
- 239000002355 dual-layer Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 229920001971 elastomer Polymers 0.000 description 5
- 210000000867 larynx Anatomy 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 201000004193 respiratory failure Diseases 0.000 description 5
- 239000004945 silicone rubber Substances 0.000 description 5
- 210000004872 soft tissue Anatomy 0.000 description 5
- 210000003437 trachea Anatomy 0.000 description 5
- 206010008501 Cheyne-Stokes respiration Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 210000000621 bronchi Anatomy 0.000 description 4
- 229910002092 carbon dioxide Inorganic materials 0.000 description 4
- 239000001569 carbon dioxide Substances 0.000 description 4
- 239000004744 fabric Substances 0.000 description 4
- 210000002454 frontal bone Anatomy 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 210000000214 mouth Anatomy 0.000 description 4
- 210000000492 nasalseptum Anatomy 0.000 description 4
- 210000002345 respiratory system Anatomy 0.000 description 4
- 210000003625 skull Anatomy 0.000 description 4
- 230000000153 supplemental effect Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 206010003497 Asphyxia Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 241000590419 Polygonia interrogationis Species 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 230000006735 deficit Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 210000001508 eye Anatomy 0.000 description 3
- 210000000887 face Anatomy 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 210000003026 hypopharynx Anatomy 0.000 description 3
- 230000002452 interceptive effect Effects 0.000 description 3
- 230000003340 mental effect Effects 0.000 description 3
- 210000001989 nasopharynx Anatomy 0.000 description 3
- 210000003455 parietal bone Anatomy 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000000750 progressive effect Effects 0.000 description 3
- 230000003252 repetitive effect Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 239000005060 rubber Substances 0.000 description 3
- 210000001584 soft palate Anatomy 0.000 description 3
- 239000003351 stiffener Substances 0.000 description 3
- 210000000115 thoracic cavity Anatomy 0.000 description 3
- 210000000779 thoracic wall Anatomy 0.000 description 3
- 210000002105 tongue Anatomy 0.000 description 3
- 238000009423 ventilation Methods 0.000 description 3
- 210000001260 vocal cord Anatomy 0.000 description 3
- 208000007590 Disorders of Excessive Somnolence Diseases 0.000 description 2
- 206010013801 Duchenne Muscular Dystrophy Diseases 0.000 description 2
- 206010041349 Somnolence Diseases 0.000 description 2
- 206010067775 Upper airway obstruction Diseases 0.000 description 2
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000000806 elastomer Substances 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 210000002532 foramen magnum Anatomy 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 238000007373 indentation Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 208000001797 obstructive sleep apnea Diseases 0.000 description 2
- 210000003300 oropharynx Anatomy 0.000 description 2
- 238000006213 oxygenation reaction Methods 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 208000037821 progressive disease Diseases 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000003582 temporal bone Anatomy 0.000 description 2
- 230000002123 temporal effect Effects 0.000 description 2
- 229920002725 thermoplastic elastomer Polymers 0.000 description 2
- 210000001944 turbinate Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000750142 Auricula Species 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020591 Hypercapnia Diseases 0.000 description 1
- 206010021133 Hypoventilation Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010023506 Kyphoscoliosis Diseases 0.000 description 1
- 206010024971 Lower respiratory tract infections Diseases 0.000 description 1
- 206010027940 Mood altered Diseases 0.000 description 1
- 241000208125 Nicotiana Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010073310 Occupational exposures Diseases 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- 206010031123 Orthopnoea Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 206010062519 Poor quality sleep Diseases 0.000 description 1
- 235000006894 Primula auricula Nutrition 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010070833 Respiratory muscle weakness Diseases 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 229920004482 WACKER® Polymers 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 230000037007 arousal Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000006931 brain damage Effects 0.000 description 1
- 231100000874 brain damage Toxicity 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000011513 continuous positive airway pressure therapy Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 210000002409 epiglottis Anatomy 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000001983 hard palate Anatomy 0.000 description 1
- 201000000615 hard palate cancer Diseases 0.000 description 1
- 208000000122 hyperventilation Diseases 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 210000001847 jaw Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 210000001699 lower leg Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000007510 mood change Effects 0.000 description 1
- 208000001022 morbid obesity Diseases 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 201000006938 muscular dystrophy Diseases 0.000 description 1
- 230000003274 myotonic effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 231100000675 occupational exposure Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001936 parietal effect Effects 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000012858 resilient material Substances 0.000 description 1
- 210000003019 respiratory muscle Anatomy 0.000 description 1
- 238000002644 respiratory therapy Methods 0.000 description 1
- 230000001020 rhythmical effect Effects 0.000 description 1
- 210000000614 rib Anatomy 0.000 description 1
- 206010039722 scoliosis Diseases 0.000 description 1
- 229920000260 silastic Polymers 0.000 description 1
- 201000002859 sleep apnea Diseases 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 238000010321 sleep therapy Methods 0.000 description 1
- 230000037321 sleepiness Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 229920003051 synthetic elastomer Polymers 0.000 description 1
- 239000005061 synthetic rubber Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012876 topography Methods 0.000 description 1
- 230000003519 ventilatory effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000004018 waxing Methods 0.000 description 1
Landscapes
- Respiratory Apparatuses And Protective Means (AREA)
Abstract
A nasal mask system, comprising: a cushion assembly (250) including a sealing region having a nose ridge region (252), sides of nose region, corners of nose region (254), and a top lip region (255) adapted to seal around both nares of the patient’s nose. The nose ridge region is adapted to be positioned and seal along a nasal cartilage region which is above the pronasale and below a nasal bone region of the patient’s nasal bridge. The sides of nose region is adapted to extend across the alar of flares of the patient’s nose. The sealing region includes a membrane seal (260) that extends around an entire perimeter of the sealing region and an undercushion (265) that is only provided in the top lip and corners of nose regions, such that the sides of nose region includes a single layer or membrane only structure configured and arranged to seal along the alar or flares of the patient’s nose and prevent excess pressure on the alar or flares of the patient’s nose.
Description
(A) NASAL MASK SYSTEM
2 (B) CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims the benefit of Australian Provisional Application No. AU
2011904754, filed November 15, 2011, which is incorporated herein by reference in
its entirety.
3 (C) STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR
DEVELOPMENT
Not Applicable
4 (D) THE NAMES OF PARTIES TO A JOINT RESEARCH DEVELOPMENT
Not Applicable
(E) SEQUENCE LISTING
Not Applicable
6 (F) BACKGROUND OF TECHNOLOGY
6.1 (1) FIELD OF TECHNOLOGY
The present technology relates to treatment of respiratory disorders, and to
procedures to prevent respiratory disorders. In particular, the present technology
relates to medical devices, and their use for treating respiratory disorders and for
preventing respiratory disorders. More particularly, the present technology relates to
a nasal mask system used for treatment, e.g., of Sleep Disordered Breathing (SDB)
with Continuous Positive Airway Pressure (CPAP) or Non-Invasive Positive Pressure
Ventilation (NIPPV).
6.2 (2) DESCRIPTION OF THE RELATED ART
The respiratory system of the body facilitates gas exchange. The nose and mouth
form the entrance to the airways of a patient.
The airways consist of a series of branching tubes, which become narrower,
shorter and more numerous as they penetrate deeper into the lung. The prime function
of the lung is gas exchange, allowing oxygen to move from the air into the venous
blood and carbon dioxide to move out. The trachea divides into right and left main
bronchi, which further divide eventually into terminal bronchioles. The bronchi make
up the conducting airways, and do not take part in gas exchange. Further divisions of
the airways lead to the respiratory bronchioles, and eventually to the alveoli. The
alveolated region of the lung is where the gas exchange takes place, and is referred to
as the respiratory zone. See West, Respiratory Physiology- the essentials.
A range of respiratory disorders exist.
Obstructive Sleep Apnoea (OSA), a form of Sleep Disordered Breathing (SDB), is
characterized by occlusion of the upper air passage during sleep. It results from a
combination of an abnormally small upper airway and the normal loss of muscle tone
in the region of the tongue, soft palate and posterior oropharyngeal wall during sleep.
The condition causes the affected patient to stop breathing for periods typically of 30
to 120 seconds duration, sometimes 200 to 300 times per night. It often causes
excessive daytime somnolence, and it may cause cardiovascular disease and brain
damage. The syndrome is a common disorder, particularly in middle aged overweight
males, although a person affected may have no awareness of the problem. See US
Patent 4,944,310 (Sullivan).
Cheyne-Stokes Respiration (CSR) is a disorder of a patient's respiratory
controller in which there are rhythmic alternating periods of waxing and waning
ventilation, causing repetitive de-oxygenation and re-oxygenation of the arterial
blood. It is possible that CSR is harmful because of the repetitive hypoxia. In some
patients CSR is associated with repetitive arousal from sleep, which causes severe
sleep disruption, increased sympathetic activity, and increased afterload. See US
Patent 6,532,959 (Berthon-Jones).
Obesity Hyperventilation Syndrome (OHS) is defined as the combination of
severe obesity and awake chronic hypercapnia, in the absence of other known causes
for hypoventilation. Symptoms include dyspnea, morning headache and excessive
daytime sleepiness.
Chronic Obstructive Pulmonary Disease (COPD) encompasses any of a group of
lower airway diseases that have certain characteristics in common. These include
increased resistance to air movement, extended expiratory phase of respiration, and
loss of the normal elasticity of the lung. Examples of COPD are emphysema and
chronic bronchitis. COPD is caused by chronic tobacco smoking (primary risk factor),
occupational exposures, air pollution and genetic factors. Symptoms include:
dyspnoea on exertion, chronic cough and sputum production.
Neuromuscular Disease (NMD) is a broad term that encompasses many diseases
and ailments that impair the functioning of the muscles either directly via intrinsic
muscle pathology, or indirectly via nerve pathology. Some NMD patients are
characterised by progressive muscular impairment leading to loss of ambulation,
being wheelchair-bound, swallowing difficulties, respiratory muscle weakness and,
eventually, death from respiratory failure. Neuromuscular disorders can be divided
into rapidly progressive and slowly progressive: (i) Rapidly progressive disorders:
Characterised by muscle impairment that worsens over months and results in death
within a few years (e.g. Amyotrophic lateral sclerosis (ALS) and Duchenne muscular
dystrophy (DMD) in teenagers); (ii) Variable or slowly progressive disorders:
Characterised by muscle impairment that worsens over years and only mildly reduces
life expectancy (e.g. Limb girdle, Facioscapulohumeral and Myotonic muscular
dystrophy). Symptoms of respiratory failure in NMD include: increasing generalised
weakness, dysphagia, dyspnoea on exertion and at rest, fatigue, sleepiness, morning
headache, and difficulties with concentration and mood changes.
Chest wall disorders are a group of thoracic deformities that result in inefficient
coupling between the respiratory muscles and the thoracic cage. The disorders are
usually characterised by a restrictive defect and share the potential of long term
hypercapnic respiratory failure. Scoliosis and/or kyphoscoliosis may cause severe
respiratory failure. Symptoms of respiratory failure include: dyspnoea on exertion,
peripheral oedema, orthopnoea, repeated chest infections, morning headaches, fatigue,
poor sleep quality and loss of appetite.
Otherwise healthy individuals may take advantage of systems and devices to
prevent respiratory disorders from arising.
6.2.1 Systems
One known product used for treating sleep disordered breathing is the S9 Sleep
Therapy System, manufactured by ResMed.
6.2.2 Therapy
Nasal Continuous Positive Airway Pressure (CPAP) therapy has been used to
treat Obstructive Sleep Apnea (OSA). The hypothesis is that continuous positive
airway pressure acts as a pneumatic splint and may prevent upper airway occlusion by
pushing the soft palate and tongue forward and away from the posterior
oropharyngeal wall.
Non-invasive ventilation (NIV) has been used to treat OHS, COPD, NMD and
Chest Wall disorders.
6.2.3 Patient Interface
The application of a supply of air at positive pressure to the entrance of the
airways of a patient, e.g., while a patient sleeps, is facilitated by the use of a patient
interface, such as a nasal mask, full-face mask or nasal pillows.
Known patient interface devices suffer from being one or more of obtrusive,
aesthetically undesirable, poorly fitting, difficult to use and uncomfortable, especially
when worn for long periods of time or when a patient is unfamiliar with a system.
6.2.3.1 Seal-forming portion
Patient interfaces typically include a seal-forming portion.
A range of patient interface seal-forming portion technologies are disclosed in
the following patent applications, assigned to ResMed Limited: ,310;
,513; ,785.
6.2.3.2 Positioning and stabilising
A seal-forming portion of a patient interface used for positive air pressure
therapy is subject to the corresponding force of the air pressure to disrupt a seal. Thus
a variety of techniques have been used to position the seal-forming portion, and to
maintain it in sealing relation with the appropriate portion of the face.
One technique is the use of adhesives. See for example US Patent publication
US 2010/0000534.
Another technique is the use of one or more straps and stabilising harnesses.
6.2.3.3 Vent technologies
Some forms of patient interface systems may include a vent to allow the
washout of exhaled carbon dioxide.
ResMed Limited has developed a number of mask vent technologies. See WO
1998/034,665; ,381; US 6,581,594; US Patent Application; US
2009/0050156; US Patent Application 2009/0044808.
7 (G) BRIEF SUMMARY OF TECHNOLOGY
The present technology is directed towards providing medical devices used in
the diagnosis, treatment or prevention of respiratory disorders having one or more of
improved comfort, cost, efficacy, ease of use and manufacturability.
A first aspect of the present technology relates to apparatus used in diagnosis,
treatment or prevention of a respiratory disorder.
Another aspect of the present technology relates to methods used in diagnosis,
treatment or prevention of a respiratory disorder.
One aspect of the present technology is a patient interface that is one or more of
comfortable, effective, simple to use, unobtrusive and with a wide fit range.
An aspect of one form of the present technology is a patient interface that avoids
a jetting effect of nasal pillows or prongs, and/or a feeling of discomfort from locating
a portion of a mask within a nasal cavity of a patient.
An aspect of one form of the present technology is a nasal mask that is easy to
put on, and may avoid a need for headgear straps to interfere with, or cross the ears in
use, and may avoid interfering or crossing the ears while putting on or removing.
Another aspect of one form of the present technology is a method of putting on
or removing a mask.
In one form of the present technology, a small, unobtrusive nasal mask is
provided.
In one form of the present technology, a nasal mask is provided that does not
form a seal on a lower lip, or a chin of a patient.
In one form of the present technology, a patient interface is provided that does
not exert a rearward force on the mandible, e.g. the patient interface does not push on
the mandible from the anterior towards the posterior.
In one form of the present technology, a patient interface is provided that does
not comprise a rigid shell or rigid frame.
In one form of the present technology, a patient interface is provided that
comprises a plenum chamber constructed from a flexible or semi-rigid material, for
example a flexible rubber of a suitable thickness (e.g. silicone with a type A hardness
in the range of about 35 to about 45, and about 1.5mm to about 3mm thick).
In one form of the technology, a nasal mask is provided that does not require
engagement or disengagement of a clip to don or remove the mask.
An aspect of one form of the present technology is a patient interface
comprising a seal-forming portion having a first sealing region that is constructed to
have little nor no resistance to compression, and a second sealing region that is
constructed to substantially resist a compressive force (e.g. as a result of headgear
tension). In an example in use, the first sealing region is arranged to overlay a portion
of the cartilaginous framework of the nose, and the second sealing region is arranged
to overlay a portion of a bone region the face. In an example, the bone region of the
face is a region adjacent the ala, and optionally adjacent to the alar crest point.
According to one form of the present technology, a patient interface is provided
that comprises: (i) a seal-forming portion that in use overlays at least part of a top lip
region of a patient's face, and a portion of the cartilaginous framework of the nose;
and (ii) a seal positioning and stabilising structure that may be donned and removed
without interfering with the ears of the patient.
Another aspect of one form of the present technology is a patient interface
having a seal-forming portion associated with a two point connection with a seal
positioning and stabilising structure. In an example, the patient interface does not
comprise a forehead support. In an additional or alternative example, the seal
positioning and stabilising structure comprises a non-rigid or flexing connection
element.
Another aspect of one form of the present technology is a patient interface that
is moulded or otherwise constructed with a clearly defined perimeter shape which is
intended to match that of an intended wearer in use.
Another aspect of one form of the present technology is a patient interface that
is constructed and arranged so that while forming a seal on at least part of the
cartilaginous framework of the nose, it avoids or reduces a tendency to restrict nasal
air flow therethrough.
According to one form of the present technology, a patient interface is provided
that comprises a first superior sealing portion that in use overlays a portion of the
cartilaginous framework of the nose, and a second inferior sealing portion that in use
overlays a portion of the upper lip and wherein in use, a relatively larger portion of a
headgear sealing force is directed towards the portion of the upper lip and the
underlying maxilla, teeth or gum than is directed towards the cartilaginous framework
of the nose.
Another aspect of one form of the present technology is a patient interface that
is constructed and arranged to avoid or reduce a tendency to put unnecessary pressure
on the nasal septum.
According to one form of the present technology, a patient interface is provided
that in use forms a seal on a portion of an upper lip of a patient, and which comprises
a plenum chamber having a wall and wherein a first portion of the wall that is
constructed to be located adjacent the septum in use has a relatively less stiff spring
constant that portions of the wall that are adjacent to said first portion.
Another aspect of one form of the present technology is a patient interface that
while forming a seal on a portion of the cartilaginous framework of the nose, provides
an effective or improved seal on the region of the nose near a junction between the
greater alar cartilage and the lateral cartilage.
According to one form of the present technology, a patient interface is provided
that comprises a sealing flange that defines a generally T-shaped, or three lobed
orifice. In an example, the sealing flange includes a membrane and a sealing flap that
protrudes from the edge of the membrane along its inner perimeter in each side of
nose region. The edge of the membrane along its inner perimeter along with the edge
of each sealing flap along its inner perimeter cooperate to define an orifice into the
plenum chamber. In an example, such orifice includes a general T-shape, or three
lobed orifice, including an upper orifice portion (along vertical axis v as viewed in
Fig. 3-20) and a lower orifice portion (along horizontal axis h as viewed in Fig. 3-20)
that extends generally transverse to the upper orifice portion.
According to one form of the present technology, an inner edge of a sealing
flange is spring biased towards the face of a wearer in use, e.g. with respect to a
middle portion of the sealing flange.
Another aspect of one form of the present technology is a nasal mask that is
constructed and arrange to pivot or rotate about a top lip region upon adjustment of a
headgear tension.
Another aspect of one form of the present technology is a method of
manufacturing a patient interface.
Another aspect of one form of the present technology is a device for preventing,
treating or ameliorating one or more of OSA, CSA, OHS, COPD, NMD and chest-
wall disorders.
Another aspect of the present technology is a mask system that can
accommodate a wide range of different facial shapes including faces with high and
low nose bridge regions, and narrow and wide noses. Another aspect of the present
technology is a mask system with a wide fit range.
Another aspect of one form of the present technology is a mask system that is
small and unobtrusive, and yet is stable on the face while a patient is sleeping.
One aspect of the present technology is a mask that is constructed and arranged
to seal at its upper extent on a region of the nose that is generally above or superior to
the pronasale, or tip of the nose.
One aspect of one form of the present technology is a mask that is constructed
and arranged to seal at its upper extent at locations that are generally below or inferior
to the nasal bones.
In one form of the present technology, a mask is provided that is constructed and
arranged to have a seal forming portion that overlays a portion of the upper or
superior lip, and that overlays a portion of the cartilaginous framework of the nose,
e.g., without overlaying the nasal bones.
In one form of the present technology a mask is provided that is constructed and
arranged to have a first seal forming portion that overlays a portion of the upper or
superior lip, and a second seal-forming portion that overlays of the cartilaginous
framework of the nose, e.g., without overlaying the nasal bones.
In one form of the present technology a mask is provided that is constructed and
arranged to have a first seal forming portion that is substantially in compression, or
subject to bending forces in use, and a second seal-forming portion that is
substantially in tension in use.
In one form of the present technology a mask is provided that is constructed and
arranged to have a first seal forming portion that is relatively stiff before use, and a
second seal-forming portion that is relatively floppy before use.
Another aspect of one form of the present technology is a mask system with an
improved sealing cuff. In an example, the mask system includes a facial flap
comprising a relatively thin member formed of a flexible, e.g., and at least semi-
resilient, material. In an example, the mask system further comprises, in at least some
regions, a back-up band.
Another aspect of the present technology is a mask that is formed, moulded or
otherwise constructed with a clearly defined perimeter shape which is intended to
match that of an intended wearer.
A further aspect of the present technology is a cushion for a mask that seals at
its upper extent in a region of the nose that is generally superior to or above the
pronasale or tip of the nose, and extends across the alar or flares of the patient’s nose.
A further aspect of the present technology is a cushion for a mask that seals at
its upper extent in a region of the nose that is generally superior to or above the
pronasale or tip of the nose, and extends across the alar or flares of the patient’s nose,
e.g., not extending over or across the nasal bones of the patient’s nose.
One aspect of one form of the present technology is a cushion for a mask that
seals at its upper extent in a region of the nose that is generally close to the junction
between bone and cartilage on a range of people with larger noses, and which avoids
impinging on the sight of people with smaller noses.
In one form of the present technology, a mask system is provided that does not
require a rigid frame or skeleton, and which seals at its upper extent in a region of the
nose that is generally above or superior to the pronasale, or tip of the nose.
One aspect of the present technology is a cushion for a mask that includes a
sealing membrane and a backup band or undercushion, in at least some regions.
Another aspect of the present technology is a cushion for a nasal mask that
includes an undercushion or backup band in the region of the top lip.
Another aspect of one form of the present technology is a cushion for a nasal
mask that includes an undercushion or backup band in the region of the top lip, and no
undercushion or backup band in the sides of the nose or ridge of the nose regions to
avoid relatively high sealing forces on the sides of the nose or ridge of the nose
regions as these relatively high sealing forces may cause occlusion of the nasal
airway.
Another aspect of the present technology includes a cushion for a nasal mask,
the cushion having a sealing region, a side wall region and an attachment region,
wherein the sealing region is adapted to form a seal with a patient, the side wall
region connects the sealing region and attachment region, and the attachment region is
adapted to connect or otherwise attach to an air delivery system.
Another aspect of the present technology includes a cushion for a nasal mask,
the cushion having a sealing region and an attachment region, wherein the attachment
region comprises a decoupling element.
Another aspect of the present technology includes a cushion for a nasal mask,
the cushion having a sealing region and an attachment region, wherein the attachment
region comprises a decoupling element, the decoupling element comprising a
relatively thinner wall section. For example, the relatively thinner wall section may be
50-85% thinner.
Another aspect of the present technology includes a cushion for a nasal mask,
the cushion comprising headgear connectors integrally formed with a side wall, e.g.,
wherein the side wall is constructed of a flexible elastomer or rubber.
Another aspect of the present technology includes a cushion for a nasal mask,
the cushion comprising headgear connectors, the headgear connectors constructed and
arranged to position a portion of a sealing region superior to or above the pronasale or
tip of the patient’s nose.
Another aspect of the present technology includes a cushion for a nasal mask,
the cushion having a nose ridge region, the nose ridge region having a dip or
curvature, e.g. a local saddle region, adapted to conform to, or be complementary to
the nose ridge of the patient.
A further aspect of the present technology includes a cushion for a nasal mask,
the cushion having a nose ridge region, the nose ridge region having a relatively
longer membrane length when compared to other regions of the cushion, the relatively
longer membrane length adapted to engage a greater fit range of patient’s nose ridge
heights.
Another aspect of the present technology includes a cushion for a nasal mask,
the cushion having a sides of the nose region, the sides of the nose region having a
raised portion, the raised portion having a greater height when compared to the nose
ridge region, the raised portion adapted to engage with the sides of the patient’s nose
and ensure engagement with tall nose ridges as well as flat nose ridges.
Another aspect of the present technology includes a cushion for a nasal mask,
the cushion having a corners of the nose region, generally corresponding to the region
of the face between and including the subalare and the alar crest, the corners of the
nose region having the greatest height when compared to all other regions of the
cushion, wherein the corners of the nose region anchors the cushion in position. The
height of the corners of the nose region may be arranged to ensure seal in the corners
of the nose, as this is a particularly difficult area of the face to seal on.
Another aspect of the present technology includes a cushion for a nasal mask,
the cushion having a top lip region, the top lip region configured to conform to the
curvature of a patient’s top lip region. The top lip region may be generally rounded,
extending from a trough or dip and continuing up to the sides of the nose region. The
membrane at the top lip region may stretch across a patient’s top lip to ensure a seal
with the patient’s top lip.
Another aspect of the present technology relates to a nasal mask system
including a cushion assembly including a sealing region that provides a single orifice
adapted to surround both nares of the patient’s nose and a headgear assembly
including a pair of side straps and a rear strap. The side straps are adapted to extend
along sides of the patient’s face between the patient’s eyes and ears and engage
respective headgear connectors provided to the cushion assembly to provide a two-
point connection with the cushion assembly. The rear strap extends between the side
straps and is adapted to engage along the back or posterior of the patient’s head along,
below or inferior to the occipital bone.
Another aspect of the present technology relates to a nasal mask system
including a cushion assembly including a sealing region having a nose ridge region,
sides of nose region, corners of nose region, and a top lip region adapted to seal
around both nares of the patient’s nose. The nose ridge region is adapted to be
positioned and seal along a nasal cartilage region which is above or superior to the
pronasale and below or inferior to a nasal bone region of the patient’s nasal bridge. In
one form, the sealing region includes a membrane seal that extends around an entire
perimeter of the sealing region and an undercushion that is only provided in the top
lip and corners of nose regions.
Another aspect of the present technology relates to a nasal mask system
including a cushion assembly including a sealing region adapted to seal around both
nares of the patient’s nose, an attachment region adapted to receive an elbow
assembly, and a side wall region extending between the sealing region and the
attachment region. The sealing region has a nose ridge region, sides of nose region,
corners of nose region, and a top lip region. The side wall region includes an area
adjacent the top lip region of the sealing region that includes a thickness that is less
than corresponding thicknesses adjacent the nose ridge, sides of nose, and corners of
nose regions of the sealing region.
Another aspect of the present technology relates to a nasal mask system
including a cushion assembly including a sealing region having a nose ridge region,
sides of nose region, corners of nose region, and a top lip region adapted to seal
around both nares of the patient’s nose. The sides of nose region includes a portion
adapted to be positioned and seal along a region adjacent the junction between the
nasal greater alar cartilage and the lateral nasal cartilage of the patient’s nose.
Another aspect of the present technology relates to a patient interface for
applying a supply of air at positive pressure to the entrance of a patient's airways. The
patient interface includes a nasal mask and a positioning and stabilising structure.
The nasal mask has a seal forming portion constructed and arranged to form a seal on
a portion of an upper lip of a patient, and to form a seal on a portion of a cartilaginous
framework of the patient's nose. The nasal mask further has a plenum chamber that
receives in use a portion of the patient's nose including the pronasale. The positioning
and stabilising structure includes a pair of side straps that provide a two-point
connection to the nasal mask and being constructed and arranged to be donned or
removed without the side straps passing inferior to the patient’s ears.
Another aspect of the present technology relates to a method for fitting a patient
interface to a patient. The method includes positioning a sealing region of the patient
interface with respect the patient's nose such that the sealing region surrounds both
nares and engaging headgear straps of the patient interface with the patient’s head
without passing straps inferior to the patient’s ears.
Another aspect of the present technology relates to a nasal mask for delivery of
a supply of air to the entrance of a patient's airways. The nasal mask includes a
superior sealing portion and an inferior sealing portion. The superior sealing portion
is constructed and arranged to be located on a portion of the cartilaginous framework
of the nose, and to form a seal therewith without exerting a sealing force that would
restrict a flow of air through the nasal cavity. The inferior sealing portion is
constructed and arranged to be located in part on a portion of an upper lip of a patient
and to direct a sealing force to a portion of a maxilla bone of the patient.
Another aspect of the present technology relates to a nasal mask defining a
breathing chamber for delivery of a supply of gas at positive pressure to the airways
of a patient. The nasal mask includes a vent ad a cushion. The vent is adapted to
exhaust breathable gas and is adapted to be sufficiently rigid to avoid collapse. The
cushion includes a sealing cuff and headgear connectors. The sealing cuff comprises
a membrane seal and an undercushion. The membrane seal extends about a perimeter
of the cushion including a nose ridge region of the cushion and a side of the nose
region of the cushion, and the undercushion is located in a top lip region of the
cushion and does not extend to the nose ridge region of the cushion or the side of the
nose region of the cushion. The headgear connectors are formed with a side wall of
the cushion.
Another aspect of the present technology relates to a patient interface for
applying a supply of air at positive pressure to the entrance of a patient's airways. The
patient interface includes a nasal mask and a positioning and stabilising structure.
The nasal mask has a seal forming portion constructed and arranged to form a seal on
a portion of an upper lip of a patient, and to form a seal on a portion of a cartilaginous
framework of the patient's nose. The nasal mask further has a plenum chamber that
receives in use a portion of the patient's nose including the pronasale. The positioning
and stabilising structure provides a sealing vector oriented at an angle with respect to
a Frankfort horizontal direction. The positioning and stabilising structure includes a
two-point connection to the nasal mask.
Another aspect of the present technology relates to a patient interface for
applying a supply of air at positive pressure to the entrance of a patient's airways. The
patient interface includes a nasal mask and a positioning and stabilising structure.
The nasal mask has a seal forming portion constructed and arranged to form a seal on
a portion of an upper lip of a patient, and to form a seal on a portion of a cartilaginous
framework of the patient's nose. The nasal mask further has a plenum chamber that
receives in use a portion of the patient's nose including the pronasale. The positioning
and stabilising structure provides a sealing vector oriented at an angle with respect to
a Frankfort horizontal direction. The nasal mask does not include a forehead support.
Another aspect of the present technology relates to a patient interface for
applying a supply of air at positive pressure to the entrance of a patient's airways. The
patient interface includes a nasal mask and a positioning and stabilising structure.
The nasal mask has a seal forming portion constructed and arranged to form a seal on
a portion of an upper lip of a patient, and to form a seal on a portion of a cartilaginous
framework of the patient's nose. The nasal mask further has a plenum chamber that
receives in use a portion of the patient's nose including the pronasale. The positioning
and stabilising structure provides a sealing vector oriented at an angle with respect to
a Frankfort horizontal direction. The positioning and stabilising structure includes a
pair of side straps adapted to extend towards and over a crown of the patient’s head.
Of course, portions of the aspects may form sub-aspects of the present
technology. Also, various ones of the sub-aspects and/or aspects may be combined in
various manners and also constitute additional aspects or sub-aspects of the present
technology.
Other features of the technology will be apparent from consideration of the
information contained in the following detailed description, abstract, drawings and
claims.
8 (H) BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWINGS
The present technology is illustrated by way of example, and not by way of
limitation, in the figures of the accompanying drawings, in which like reference
numerals refer to similar elements including:
8.1 TREATMENT SYSTEMS
Fig. 1a shows a system in accordance with the present technology. A patient
1000 wearing a patient interface 3000, receives a supply of air at positive pressure
from a PAP device 4000. Air from the PAP device is humidified in a humidifier 5000,
and passes along an air circuit 4170 to the patient 1000. The PAP device 4000,
humidifier 5000 and air circuit 4170 may be connected to a patient interface 3000 in
accordance with the present technology.
8.2 THERAPY
8.2.1 Respiratory system
Fig. 2a shows an overview of a human respiratory system including the nasal
and oral cavities, the larynx, vocal folds, oesophagus, trachea, bronchus, lung,
alveolar sacs, heart and diaphragm.
Fig. 2b shows a view of a human upper airway including the nasal cavity, nasal
bone, lateral nasal cartilage, greater alar cartilage, nostril, lip superior, lip inferior,
larynx, hard palate, soft palate, oropharynx, tongue, epiglottis, vocal folds,
oesophagus and trachea.
8.2.2 Facial anatomy
Fig. 2c is a front view of a face with several features of surface anatomy
identified including the lip superior, upper vermillion, lower vermillion, lip inferior,
mouth width, endocanthion, a nasal ala, nasolabial sulcus and cheilion.
Fig. 2d is a side view of a head with several features of surface anatomy
identified including glabella, sellion, pronasale, subnasale, lip superior, lip inferior,
supramenton, nasal ridge, otobasion superior and otobasion inferior. Also indicated
are the directions superior & inferior, and anterior & posterior.
Fig. 2e is a further side view of a head. The approximate locations of the
Frankfort horizontal and nasolabial angle are indicated.
Fig. 2f shows a base view of a nose.
Fig. 2g shows a side view of the superficial features of a nose.
Fig. 2h shows subcutaneal structures of the nose, including the cartilaginous
framework comprising the lateral cartilage, septum cartilage, greater alar cartilage,
lesser alar cartilage and also shows the fibrofatty tissue.
Fig. 2i shows a medial dissection of a nose, approximately several millimeters
from a sagittal plane, amongst other things showing the septum cartilage and medial
crus of greater alar cartilage.
Fig. 2j shows a front view of the bones of a skull including the frontal,
temporal, nasal and zygomatic bones. Nasal concha are indicated, as are the maxilla,
mandible and mental protuberance.
Fig. 2k shows a lateral view of a skull with the outline of the surface of a head,
as well as several muscles. The following bones are shown: frontal, sphenoid, nasal,
zygomatic, maxilla, mandible, parietal, temporal and occipital. The mental
protuberance is indicated. The following muscles are shown: digastricus, masseter
sternocleidomastoid and trapezius.
8.3 PATIENT INTERFACE
Fig. 3-1 is a perspective view of a nasal mask system according to an example
of the present technology.
Fig. 3-2 is a side view of a nasal mask system according to an example of the
present technology. The nasal mask system is shown overlaying a head to indicate the
approximate relative location of the headgear in use.
Fig. 3-3 is a front view of a nasal mask system according to an example of the
present technology.
Fig. 3-4 is a perspective front view of a cushion of a nasal mask system
according to an example of the present technology.
Fig. 3-5 is a perspective rear view of a cushion of a nasal mask system
according to an example of the present technology.
Fig. 3-6 is a bottom view of a cushion of a nasal mask system according to an
example of the present technology.
Fig. 3-7 is a top view of a cushion of a nasal mask system according to an
example of the present technology.
Fig. 3-8 is a front view of a cushion of a nasal mask system according to an
example of the present technology.
Fig. 3-9 is a rear view of a cushion of a nasal mask system according to an
example of the present technology.
Fig. 3-10 is a cross-sectional view of the cushion of the nasal mask system of
Fig. 3-9.
Fig. 3-11 is a perspective view of an elbow assembly of a nasal mask system
according to an example of the present technology.
Fig. 3-12 is a rear view of an elbow assembly of a nasal mask system according
to an example of the present technology.
Fig. 3-13 is a cross-sectional view of the elbow assembly of a nasal mask system
of Fig. 3-12.
Fig. 3-14 is a perspective rear view of a cushion of a nasal mask system
according to another example of the present technology.
Fig. 3-15 is a top view of the cushion of Fig. 3-14.
Fig. 3-16 is a bottom view of the cushion of Fig. 3-14.
Fig. 3-17 is a front view of the cushion of Fig. 3-14.
Fig. 3-18 is a cross-section view of the cushion of Fig. 3-17.
Fig. 3-19 is an enlarged view of a portion of Fig. 3-18.
Fig. 3-20 is a rear view of the cushion of Fig. 3-14.
Fig. 3-21 is a side view of the cushion of Fig. 3-14.
Fig. 3-22 is a rear view of the cushion of Fig. 3-14 showing cross-sectional
lines.
Fig. 3-23 is a cross-section through line 3-23 - 3-23 of Fig. 3-22.
Fig. 3-24 is a cross-section through line 3-24 - 3-24 of Fig. 3-22.
Fig. 3-25 is a cross-section through line 3-25 - 3-25 of Fig. 3-22.
Fig. 3-26 is a cross-section through line 3-26 - 3-26 of Fig. 3-22.
Fig. 3-27 is a cross-section through line 3-27 - 3-27 of Fig. 3-22.
Fig. 3-28 is a cross-section through line 3-28 - 3-28 of Fig. 3-22.
Fig. 3-29 is a cross-section through line 3-29 - 3-29 of Fig. 3-22.
Fig. 3-30 is a cross-section through line 3-30 - 3-30 of Fig. 3-22.
Figs. 3-31 to 3-34 are sequential views showing exemplary steps for donning a
nasal mask system according to an example of the present technology.
Fig. 3-35 is a cross-sectional view showing a nasal mask system engaged with a
patient’s face according to an example of the present technology.
Fig. 3-36 is a cross-sectional view showing a nasal mask system engaged with a
patient’s face according to an example of the present technology.
Fig. 3-37 is another perspective view of the cushion of Fig. 3-14.
Figs. 3-38 shows a cushion assembly engaged with the patient’s face and under
pressure or inflated in use according to an example of the present technology.
Fig. 3-39 is a schematic rear view of a cushion assembly showing the sealing
portions engaged with the patient’s face in use according to an example of the present
technology.
Figs. 31 to 38 show various views of a cushion assembly according to
another example of the present technology.
Figs. 31 to 310 show various views of a cushion assembly according to
another example of the present technology.
8.4 PAP DEVICE
Fig. 4a shows a PAP device in accordance with one form of the present
technology.
9 (I) DETAILED DESCRIPTION ILLUSTRATED EXAMPLES
Before the present technology is described in further detail, it is to be
understood that the technology is not limited to the particular examples described
herein, which may vary. It is also to be understood that the terminology used in this
disclosure is for the purpose of describing only the particular examples discussed
herein, and is not intended to be limiting.
The following description is provided in relation to several examples which
may share common characteristics and features. It is to be understood that one or
more features of any one example may be combinable with one or more features of
the other examples. In addition, any single feature or combination of features in any
of the examples may constitute additional examples.
In this specification, the word “comprising” is to be understood in its “open”
sense, that is, in the sense of “including”, and thus not limited to its “closed” sense,
that is the sense of “consisting only of”. A corresponding meaning is to be attributed
to the corresponding words “comprise", "comprised" and "comprises" where they
appear.
The term "air" will be taken to include breathable gases, for example air with
supplemental oxygen. Hence a supply of air may correspond to a supply of gas
including air and supplemental oxygen.
Examples of the technology are directed towards a nasal mask system that is
easy and quick to fit (e.g., with little or no adjustment), enable reduced strap tension,
is manufacturable in high volumes, provides high consumer appeal, provides comfort
and seal, provides reliable quality, unobtrusive, and/or fits a large majority of the
population.
One or more examples may include exemplary metrics, e.g., dimensions,
angles, percentages, etc. Although specific metrics and ranges therefore may be
provided, it is to be understood that these metrics and ranges are merely exemplary
and other metrics and ranges are possible depending on application. For example,
metrics/ranges that vary from those provided +/- 10-20% may be suitable for
particular applications.
9.1 TREATMENT SYSTEMS
In one form, the present technology comprises apparatus for treating a
respiratory disorder. In an example, the apparatus comprises a flow generator or
blower for supplying pressurised respiratory gas, such as air, to the patient 1000 via
an air delivery tube leading to a patient interface 3000 (e.g., see Fig. 1a). In one form,
the apparatus is a CPAP system, in other forms the apparatus is a ventilator.
9.2 THERAPY
In one form, the present technology comprises a method for treating a
respiratory disorder comprising the step of applying positive pressure to the entrance
of the airways of a patient 1000 (e.g., see Fig. 1a).
9.2.1 Nasal CPAP for OSA
In one form, the present technology comprises a method of treating Obstructive
Sleep Apnea in a patient by applying nasal continuous positive airway pressure to the
patient.
9.3 PATIENT INTERFACE 3000
A patient interface 3000 in accordance with one aspect of the present technology
comprises the following functional aspects: a seal-forming structure 3100, a plenum
chamber 3200, a positioning and stabilising structure 3300 and a connection port 3600
for connection to an air circuit 4170 (e.g., see Fig. 3-2). In some forms a functional
aspect may be provided by one or more physical components. In some forms, one
physical component may provide one or more functional aspects. In use the seal-
forming structure 3100 is arranged to surround an entrance to the airways of the
patient so as to facilitate the supply of air at positive pressure to the airways.
In an example, the plenum chamber 3200 and the seal forming structure 3100
are moulded in one piece. In another example they are formed as two or more separate
components.
A patient interface 3000 in accordance with one form of the present
technology is nasal mask system 100. As shown in Figs. 3-1 to 3-3, nasal mask
system 100 in accordance with the present technology may comprise a headgear
assembly 110, an elbow assembly 120, an air delivery assembly 130 and a cushion
assembly or cushion 150. Figs. 3-4 to 3-10 show various views of the cushion
assembly 150, and Figs. 3-11 to 3-12 show various views of the elbow assembly 120.
A plenum chamber 3200 in accordance with one form of the present
technology is cushion assembly 150. Cushion assembly 150 may be adapted to
sealingly engage with a patient’s airway, including a patient’s nose. As shown in Figs
3-1 to 3-3, cushion assembly 150 may receive breathable gas from air delivery
assembly 130 and/or elbow assembly 120, and be supported in position by headgear
assembly 110.
Cushion assembly 150 may comprise a sealing region or sealing cuff 151, two
headgear connectors 156, a side wall or side wall region 157 and an attachment region
158. In an example, cushion assembly 150 may be formed from a flexible elastomer
or rubber.
Figs. 3-14 to 3-30, 3-35, and 31 to 32 show various views of a cushion
assembly 250 according to another example of the present technology, which is
similar to the cushion assembly 150. As described below, the cushion assembly 250
includes a thinner wall section adjacent a top lip region of the sealing region of the
cushion assembly (e.g., to avoid excessive pressure on the patient’s columella and
septum). Also, each side of the nose region of the sealing region includes a wing or
sealing flap adapted to form a seal on the region adjacent the junction between the
nasal greater alar cartilage and the lateral nasal cartilage of the patient’s nose.
In the illustrated example of Figs. 3-14 to 3-21, D is about 85-105 mm (e.g.,
about 97 mm), D is about 35-55 mm (e.g., about 48 mm), D is about 35-55 mm
(e.g., about 44 mm), D is about 30-50 mm (e.g., about 41 mm), D is about 25-45
mm (e.g., about 35 mm), D is about 20-30 mm (e.g., about 26 mm), D is about 40-
60 mm (e.g., about 50 mm), and D is about 20-30 mm (e.g., about 23 mm).
Although specific dimensions are provided, it is to be understood that these
dimensions are merely exemplary and other dimensions are possible depending on
application. For example, the exemplary dimensions may vary by +/20% or more
or less depending on application.
9.3.1 Seal-forming structure 3100
In one form of the present technology, a seal-forming structure 3100 provides a
sealing-forming surface, and may additionally provide a cushioning function.
In an example, a seal-forming structure 3100 in accordance with the present
technology is constructed from a soft, flexible, resilient material such as silicone.
In one form, the seal-forming structure 3100 comprises a sealing flange 3110
and a support flange 3120. In one form of the present technology, sealing flange 3110
includes membrane 160 of the sealing region 151 and support flange 3120 includes
undercushion or backup band 165 of the sealing region 151 (e.g., see Fig. 3-10). In an
example, the sealing flange 3110 comprises a relatively thin member with a thickness
of less than about 1mm, for example about 0.25mm to about 0.45mm that extends
around the perimeter 3210 of the plenum chamber 3200. In an example, the support
flange 3120 is relatively thicker than the sealing flange 3110. The support flange 3120
is disposed between the sealing flange 3110 and the marginal edge 3220 of the
plenum chamber 3200, and extends at least part of the way around the perimeter 3210
of the plenum chamber 3200. The support flange 3120 is a spring-like element and
functions to support the sealing flange 3110 from buckling in use. In use the sealing
flange 3110 can readily respond to system pressure in the plenum chamber 3200
acting on its underside to urge it into tight sealing engagement with the face.
In one form of the present technology, seal-forming structure 3100 comprises a
superior sealing portion 3102 and an inferior sealing portion 3104 (e.g., see Figs. 3-10
and 3-21). The superior sealing portion 3102 and the inferior sealing portion 3104 are,
e.g., located adjacent one another, and one region may blend into the other.
9.3.1.1 Superior sealing portion 3102
Superior sealing portion 3102 is constructed and arranged to form a seal on a
portion of the cartilaginous framework of the nose. In an example, superior sealing
portion 3102 is constructed from a relatively thin material, e.g. a flap, flange or
membrane of material e.g. a thermoplastic elastomer, or a silicone rubber, and further,
e.g., one that readily bends or folds in response to light finger pressure when not in
use. Depending on the shape of the nose with which it is being used, a relatively
narrow width of superior sealing portion 3102 may engage with nose ridge to form a
seal. A relatively wider portion of superior sealing portion 3102 may engage with the
skin adjacent lateral nasal cartilage to form a seal. See, e.g., Fig. 3-39.
The superior sealing portion 3102 is not designed to overlay the whole of the
nose.
In an example, the superior sealing portion 3102 is constructed and arranged,
e.g. by being thin and flexible, to be adaptable to different heights of nose ridge. In
this way, the range of faces that will be able to get a good seal is increased.
Furthermore, for a given face and nose, the flexibility of the superior sealing
portion 3102 means that a seal may be maintained should the plenum chamber 3200
may be moved, e.g. in response to movement of the air circuit 4170.
While the superior sealing portion is constructed so that it does not overlay the
nasal bones in use, certain portions of the superior sealing portion may overlay some
part of the nasal bones on some faces, depending on exactly how the patient interface
is used and the size and shape of the particular face.
In an alternative form, the superior sealing portion is constructed and arranged
to form a seal on the nasal bones in use.
9.3.1.2 Inferior sealing portion 3104
Inferior sealing portion 3104 is constructed and arranged to form seal on a
portion of the upper lip of a patient, and to direct at least part of a sealing force to the
maxilla bone of the patient. In use, part of the inferior sealing portion 3104 is located
close to the subalare and the alar crest point.
In one form, inferior sealing portion is configured to avoid excessive pressure
on the upper teeth or gums. In an example, the inferior sealing portion does not
extend along bone (e.g., frontal process of maxilla) superiorly to the alar crest point,
however it should be appreciated that in other examples it might.
Inferior sealing portion 3104 may be constructed from a single, relatively
thicker flap, rim or flange of material, e.g. a silicone rubber, or thermoplastic
elastomer, e.g. with a thickness of about 1mm to 2mm. In one form, inferior sealing
portion 3104 may be constructed from a dual flap, rim or flange, for example one
being relatively thin and the other being relatively thick. Alternatively, inferior
sealing portion 3104 may be constructed from a gel-filled bladder.
9.3.1.3 "W" shaped region
Figs. 31 to 38 show various views of a cushion assembly 350
according to another example of the present technology. In this example, the cushion
assembly includes a general “W” shape in the top lip region, i.e., general “W” shape
along the outer (inferior) edge 360(o) of the membrane 360 in the top lip region as
best shown in Fig. 34.
Figs. 31 to 38 show various views of a cushion assembly 450
according to another example of the present technology. This example shows a
cushion assembly with a general “W” shape in the top lip region. In contrast to the
example of Figs. 31 to 38, the cushion example of Figs. 31 to 38
includes general “W” shape along both the inner (superior) edge 460(i) of the
membrane 460 and the outer (inferior) edge 460(o) of the membrane in the top lip
region as best shown in Fig. 34.
In one form, the "W" portion of the top lip region is constructed and arranged
so that a middle portion of the "W" may rest on the subnasale or columella in use, in
the event of the seal forming portion shifting upwards (superiorly) in use, leaving
clearance (e.g., indicated by c in Fig. 38 which is between an inner edge of the
undercushion 465 and an inner surface of the plenum chamber) around the respective
left and right subalare.
In an example, as best shown in Figs. 46, 37, and 310, a portion of
the sealing portion may have a question-mark shaped, sickle shaped, or c-shaped
cross-section. The question-mark shaped, sickle shaped, or c-shaped cross-section
may provide the sealing portion with greater range of movement or flexibility towards
the patient’s face in use. In the illustrated example, the question-mark shaped, sickle
shaped, or c-shaped cross-section is provided to a lower portion of the undercushion
465 and/or the side wall region 457, which provides a space below the lower portion
of the undercushion 465 and adjacent the side wall region 457. For example, the
lower portion of the undercushion 465 is radially offset towards the outside of the side
wall region 457. It should be appreciated that such cross-section may be provided
around the entire perimeter of the cushion or may only be provided in selected regions
of the cushion, e.g., only in the top lip region. Also, the size and/or configuration of
such cross-section may vary in selected regions.
In the illustrated example of Figs. 31 to 38 and 31 to 38, D is
about 90-110 mm (e.g., about 105 mm), D is about 40-60 mm (e.g., about 51 mm),
D is about 40-60 mm (e.g., about 51 mm), D is about 35-55 mm (e.g., about 44
mm), D is about 30-50 mm (e.g., about 38 mm), D is about 25-35 mm (e.g., about
32 mm), D is about 45-65 mm (e.g., about 58 mm), and D is about 20-30 mm (e.g.,
about 26 mm). Although specific dimensions are provided, it is to be understood that
these dimensions are merely exemplary and other dimensions are possible depending
on application. For example, the exemplary dimensions may vary by +/20% or
more or less depending on application. For example, the sealing portion and aperture
may be wider, e.g., D is about 100-120 mm (e.g., about 114 mm), D is about 40-50
mm (e.g., about 42 mm), D is about 55-75 mm (e.g., about 68 mm), and D is about
-30 mm (e.g., about 24 mm). In another example, the sealing portion and aperture
may be narrower, e.g., D is about 90-110 mm (e.g., about 100 mm), D is about 25-
mm (e.g., about 28 mm), D is about 45-65 mm (e.g., about 54 mm), and D is
about 20-30 mm (e.g., about 24 mm).
9.3.1.4 Sealing Region
In accordance with another form of the present technology seal forming
structure 3100 comprises sealing region 151. Sealing region 151 may be adapted to
interface with the patient and form a seal with the patient’s airways. Sealing region
151 may include a nose ridge or nose ridge region 152, sides of the nose region 153,
corners of the nose region 154 and top lip region 155. Sealing region 151 may
comprise a membrane or flap type seal 160. In an example, as shown in Figs. 3-18
and 3-19, the inner edge of the membrane 260 may includes a bead 260-1, e.g., to
prevent tearing, enhance sealing along the edge. Sealing region 151 may further
comprise an undercushion or backup band 165, extending around part of or the entire
perimeter of the sealing region. A further aspect of the present technology is a cushion
for a mask that seals at its upper extent in a region of the nose that is generally above
the tip of the nose, and extends across the alar or flares of the patient’s nose.
In an example, sealing region 151 may be preformed or otherwise pre-shaped
so as to conform to that patient’s facial topography.
9.3.1.4.1 Sealing Along Nasal Ridge
One aspect of the present technology relates to sealing of the sealing region in
the nose ridge region. In an example, the sealing region in the nose ridge region is
adapted to engage along the nasal ridge between the pronasale and sellion, and along
the nasal cartilage region of the nasal ridge and below or inferior to the nasal bone.
That is, the nasal mask system is constructed to have a seal-forming region that is
substantially on at least part of the cartilaginous framework of the patient’s nose and
not on the nasal bone, i.e., seal along nasal ridge without contacting nasal bridge/skin
on the nasal bone.
For example, the sealing region 151 is adapted to be positioned and seal at its
upper extent in a region of the nose that is generally above the tip of the nose (i.e.,
above the pronasale), and extends across the alar or flares of the patient’s nose, e.g.,
not extending over or across the bone of the patient’s nose.
In an example, the sealing region 151 is positioned at its upper extent in a
region of the nose that is generally close to the junction between bone and cartilage on
a range of people with larger noses, and avoids impinging on the sight of people with
smaller noses.
9.3.1.4.2 Nose ridge Region
Nose ridge region 152 may be adapted to engage with a nose ridge of a
patient. In an example, the nose ridge region may be shaped or preformed to
accommodate a patient’s nose ridge, for example, as best shown on Fig. 3-7, the nose
ridge region may be lower (i.e., closer to the attachment region 158) than the sides of
the nose region 153. Nose ridge region 152 may comprise a membrane 160 for sealing
without an undercushion or backup band. In an example, such an arrangement
prevents excess pressure on the sensitive nose ridge region. In an example, the
membrane at the nose ridge region 152 may be relatively longer that the membrane in
other regions of the seal region, for example the top lip region 155. The membrane in
the nose ridge region 152 may be, for example, about 2-5mm in length. In an
example, the membrane in the nose ridge region 152 may be about 2-4mm in length.
In an example, the membrane in the nose ridge region 152 may be about 3mm in
length.
9.3.1.4.3 Sides of the Nose Region
Sides of the nose region 153 may be adapted to engage with the sides of a
patient’s nose. In an example, sides of the nose region 153 may be preformed to
accommodate the sides of the patient’s nose and potentially their cheeks. As best
shown on Fig. 3-5, sides of nose the region 153 extends from the apex of the cushion
at nose ridge region 152 to the corners of the nose region 154. The sides of nose the
region 153 slopes upwardly from the nose ridge region 152 to the corners of the nose
region, see for example Fig. 3-6. Sides of the nose region 153 may comprise a
membrane 160 for sealing without an undercushion or backup band. In an example,
such arrangement prevents excess pressure on the sides of the patient's nose or alar or
flares. Excess pressure on these regions may cause the cartilage of the nose to
collapse inwardly towards the septum, thereby occluding or partially occluding the
patient’s airway.
9.3.1.4.4 Corners of the Nose Region
Corners of the nose region 154 may be adapted to form a seal with the corners
of the patient’s nose. Fig. 3-6 shows the corners of the nose region 154 having an
apex or point generally indicated by H , being the maximum height of the sealing
region 151. This height is to ensure that the most force is applied to the sealing region
151 in the corners of the nose region 154, as this is a boney region of the face and is
therefore less sensitive to pressure. Furthermore, this region of the patient’s face is
particularly difficult to seal on as the geometry of the face in this region is quite
complex, so the greater the force applied to the seal in this region, the more likely a
seal will form. In addition, since lower sealing forces are required on the nose ridge
region and the sides of the nose region (for comfort and to avoid occlusion), the
sealing region must be anchored at the corners of the nose region. Corners of the nose
region 154 may comprise a membrane or membrane seal 160 and an undercushion or
backup band 165. The use of both a membrane and an undercushion may ensure a
higher sealing force in this region. In an example, the membrane may have a thickness
about 0.1-0.5mm, for example about 0.3mm. In an example, the undercushion may
have a thickness of about 0.3-2mm.
9.3.1.4.5 Top Lip Region
Top lip region 155 may be adapted to engage the surface between the patient’s
top lip and base of the nose. In an example, top lip region may have a relatively
shorter membrane length than the nose ridge region, for example a length of about
0.5-2.5mm, e.g., about 1.5-2.5mm. In an example, this shorter membrane length may
be advantageous as some patient’s only have a small space between their top lip and
the base of their nose. As best shown in Fig. 3-10, top lip region 155 may have a
membrane seal 160 and an undercushion or backup band 165. The use of both a
membrane and an undercushion may ensure a higher sealing force in this region. In an
example, the membrane may have a thickness about 0.1-0.5mm, for example about
0.3mm. In an example, the undercushion may have a thickness of about 0.3-2mm, for
example about 1.5mm. In an example, the thickness of the undercushion may vary
along the length of the top lip region, for example from about 0.3mm at the corners of
the nose region, to about 1.2mm at the centre of the top lip region.
9.3.1.5 Seal
Use of the undercushion or back-up band enables the membrane or facial flap
to be made considerably thinner than if a single unsupported flap were used. This is
highly advantageous in that a thinner flap is in turn more flexible, so as to feel softer
and more comfortable and more readily conform to irregularities in the facial contour.
It also permits the flap to more readily respond to system pressure in the breathing
chamber acting on its underside to urge it into tight sealing engagement with the face.
As noted above, the nasal mask system is constructed to have a seal-forming
region that is substantially on the cartilaginous framework on the nose (i.e., not on the
nasal bone), and which does not block the nose. In an example, this may be achieved
by providing a compression seal (e.g., using an undercushion structure) along the
patient’s top lip (e.g., inferior sealing portion) and not on the patient’s nose. Seal on
the patient’s nose (e.g., superior sealing portion) may be achieved by tension in the
membrane and/or a pneumatic seal.
For example, as shown in the cushion example of Figs. 3-14 to 3-30 and also
described in the above example, the undercushion or backup band 265 is only
provided in the top lip region 255 and the corners of the nose region 254 of the
cushion, e.g., see Figs. 3-16, 3-18, 3-22, 3-23, 3-29, and 3-30. That is, the sealing
region includes a single layer or membrane 260 only structure in the nose ridge region
252 and sides of the nose region 253 (e.g., see Figs. 3-18 and 3-22 to 3-28), and the
sealing region includes a dual layer or membrane 260 and undercushion 265 structure
in the top lip region 255 and corners of nose region 254. The dual layer structure
provides a compression seal along the top lip region and corners of nose region. In
contrast, the nose ridge region and sides of the nose region uses tension in the
membrane (edge of the membrane stretched into sealing engagement due to tension
applied to membrane) and/or pressure in the breathing chamber acting on the
membrane (pneumatic seal) to provide a seal. The single layer is also provided in the
nose ridge region and sides of the nose region to provide a softer and more flexible
seal that avoids any potential for blocking the patient’s nose, i.e., prevents excess
pressure on the sides of the patient’s nose or alar or flares which may cause the
cartilage to collapse inwardly and potentially at least partially occlude the patient’s
airway.
Thus, the cushion assembly according to an example of the present technology
provides different sealing mechanisms in different portions of the cushion. For
example, the cushion assembly may provide one mechanism of sealing in the superior
portion of the cushion (e.g., sealing by tension in the membrane and/or a pneumatic
seal) and a different mechanism of sealing in the inferior portion of the cushion (e.g.,
compression seal). In the illustrated example, the cushion assembly provides a
compression seal via a dual layer or membrane and undercushion structure. However,
it should be appreciated that the compression seal may be provided by alternative
structures, e.g., gel-filled or foam-filled pocket, thicker single wall (e.g., about 0.8 to
1.2mm thick silicone).
Figs. 3-38 shows an example of the cushion assembly 250 engaged with the
patient’s face and under pressure or inflated in use, i.e., supply of air at positive
pressure being applied to the cushion assembly 250. Fig. 3-39 shows a hatched area
along the sealing portion of the cushion assembly which illustrates a width or contact
area 280 of the sealing portion engaged with the patient’s face in use. The width or
contact area includes an inner edge 280(i) (e.g., along the edge of the orifice) and an
outer edge 280(o). Fig. 3-36 also shows the outer edge 280(o) of the contact area in
dashed lines. As illustrated, a relatively narrow width of superior sealing portion
3102 may engage with the nose ridge to form a seal, e.g., depending on the shape of
the nose with which it is being used. A relatively wider portion of superior sealing
portion 3102 may engage with the skin adjacent lateral nasal cartilage to form a seal.
In the inferior sealing portion 3104, substantially the entire width of the inferior
sealing portion may engage the skin along the corner of nose region and top lip region
to form a seal. Thus, the width or contact area of the sealing portion engaged with the
patient’s face in use may vary around the perimeter of the cushion assembly to form a
seal.
9.3.1.6 Sealing Flap
In an example, as shown in Figs., 3-14, 3-16, 3-20, 3-22, 3-26, 3-27, 3-35, and
3-36, each side of nose region 253 of the sealing region includes a portion 270, e.g., a
wing or sealing flap, that protrudes from the edge of the membrane 260 along its inner
perimeter. As best shown in Figs. 3-35 and 3-36, each sealing flap 270 is adapted to
form a seal on the region adjacent the junction between the nasal greater alar cartilage
and the lateral nasal cartilage of a patient’s nose (also referred to as the alar crease).
The exact location of the sealing flap on a face in use may vary depending on the size
and shape of the nose with which it is being used.
As illustrated, each sealing flap 270 is at least partially angled or pre-biased
outwardly away from the breathing chamber of the cushion. When engaged with the
patient’s nose, the sealing flaps are deflected towards the breathing chamber which
provides a bias for sealing in the junction noted above. That is, the shape, flexibility,
and pre-bias of the sealing flaps allows the flaps to accommodate changes in
curvature or contour in this junction (e.g., which tend to continually vary when the
nasal alar or “flare” in use) so as to maintain seal and prevent leaks in use.
In an example, the sealing flange (including membrane 260 and sealing flap
270) defines a generally T-shaped orifice. The edge of the membrane 260 along its
inner perimeter along with the edge of each sealing flap 270 along its inner perimeter
cooperate to define an orifice 275 into the plenum chamber. In an example, such
orifice 275 includes a general T-shape including an upper orifice portion 275(1)
(along vertical axis v as viewed in Fig. 3-20) and a lower orifice portion 275(2) (along
horizontal axis h as viewed in Fig. 3-20) that extends generally transverse to the upper
orifice portion 275(1).
As best shown in Fig. 3-14, the sealing flap 270 changes the curvature and/or
angle of the edge defining the orifice 275, i.e., edge of the orifice 275 curves
upwardly and outwardly away from the breathing chamber at least along the sealing
flap 270.
9.3.1.6.1 Curvature
The curvature of the cushion may vary along the patient contacting surface of
the membrane 260 in different regions of the cushion, e.g., to facilitate sealing in
different regions of the patient’s face.
For example, as shown in Fig. 3-14, the nose ridge region 252 and the top lip
region 255 each include at least a portion that is locally saddle-shaped in curvature,
e.g., curves up in one direction d1 and curves down in a different direction d2. Fig. 3-
37 is another view of the cushion 250 illustrating such saddle-shaped curvature in the
nose ridge region 252 and the top lip region 255.
It should be appreciated that the above-noted shapes of curvature are
approximate shapes and should not be limited to strict mathematical definitions of
such shapes.
In addition, it should be appreciated that regions may include similar curvature
shapes, but the magnitudes of such curvature may be different. For example, the nose
ridge region 252 and the top lip region 255 may both include at least a portion that is
locally saddle-shaped, however the magnitude of curvature in one and/or both
principle directions of such saddle-shape may be different in each region.
9.3.2 Aperture
In an example, where a single mask should be used to fit about 85% of the
female population, the undercushion aperture width (e.g., indicated at uw in Fig. 3
9 for example) is about 36mm to about 42mm, or about 38mm to about 40mm. In an
example, where a single mask should be used to fit about 85% of the male population,
the undercushion aperture width is about 40mm to about 46mm, or about 42mm to
about 44mm. In one form, to account for nose width variations of various ethnicities,
to fit up to 95% of an average population, an undercushion aperture width is about
50mm to about 56mm, or about 52mm to about 54mm.
In an example, where a single mask should be used to fit about 85% of the
female population, the membrane aperture width (e.g., indicated at mw in Fig. 39
for example) is about 23mm to about 29mm, or about 25mm to about 27mm. In an
example, where a single mask should be used to fit about 85% of the male population,
the membrane aperture width is about 39mm to about 45mm, or about 41mm to about
43mm. In one form, to account for nose width variations of various ethnicities, to fit
up to 95% of an average population, a membrane aperture width is about 49mm to
about 55mm, or about 51mm to about 53mm.
9.3.3 Plenum chamber 3200
Plenum chamber 3200 is formed in part by a side wall. In one form, the side
wall includes side wall region 157 of sealing region 151. The plenum chamber has a
perimeter 3210 that is shaped to conform generally to the surface contour of the face
of an average person (e.g., see Figs. 3-8 and 3-9). In use, a marginal edge 3220 of the
plenum chamber 3200 is positioned in close proximity to an adjacent surface of the
face (e.g., see Fig. 3-10). Actual contact with the face is provided by the seal-forming
structure 3100. In an example, the seal-forming structure 3100 extends in use about
the entire perimeter 3210 of the plenum chamber 3200. In an example, the plenum
chamber is adapted to receive a portion of the patient's nose including the pronasale,
e.g., the plenum chamber forms over and surrounds a portion of the cartilaginous
framework of the nose including the pronasale.
In an example, the walls of the plenum chamber 3200 are flexible, or semi-rigid.
In an example, plenum chamber 3200 does not include a rigid frame or shell. In an
example, the walls of the plenum chamber 3200 are not rigid, and, e.g., the walls of
the plenum chamber 3200 are not floppy. In certain forms, flexibility of the walls of
the plenum chamber 3200 assists to decouple a tube drag force from disrupting a seal.
In one form, the walls of the plenum chamber 3200 are moulded from a silicone
rubber. In an example, the walls of the plenum chamber 3200 are constructed from a
silicone rubber with a Type A indentation hardness of about 35 to about 40, and with
a thickness in the range of about 2 mm to about 4mm. In certain forms of the present
technology, the plenum chamber 3200 may have different thicknesses in different
regions.
9.3.3.1 Side Wall Region
Side wall region 157 may extend between sealing region 151 and attachment
region 158. Side wall region may be generally conical, that is, it may have a first
diameter at proximate attachment region 158 and a second diameter proximate seal
region 151, with the first diameter being less than the second diameter. Side wall
region may have a thickness of about 1.5-5mm, e.g., about 1.5-3mm, e.g., about 2mm.
Such a thickness may provide some support to the seal region 151, prevent the elbow
assembly 120 contacting the patient’s nose, and ensure that the cushion does not
collapse from headgear tension when in use.
Side wall region 157 may connect or be formed with headgear connectors 156.
Such an arrangement may replace the need for a rigid frame or skeleton, as the
headgear connectors are arrange proximal to the sealing region 151. Headgear
connectors 156 may be disposed on opposing sides of side wall 157.
9.3.3.2 Thinner Wall Section
In an example, as best shown in Figs. 3-16, 3-18, 3-23, and 3-30, the side wall
region 257 between the sealing region 251 and the attachment region 258 includes an
area 268 adjacent the top lip region 255 of the sealing region that includes a thickness
that is less than corresponding thicknesses adjacent the nose ridge, sides of nose, and
corners of nose regions of the sealing region. That is, the area 268 includes a thinner
walled cross-section adjacent the top lip region 255 of the sealing region. Such area
268 of thinner cross-section lessens the force provided by the sealing region along this
section of the top lip region 255. For example, such area 268 provides less pressure
along the top lip region 255 than the corners of nose region 254 (i.e., stiffer along the
corners of nose region than the top lip region thereby giving rise or effecting
relatively greater pressure along the corners of nose region (along the corners of the
lip adjacent the alars), in order to avoid excessive pressure on the columella or septum
of the patient’s nose which is a more sensitive region of the patient’s nose.
Figs. 3-22 to 3-30 show exemplary cross-sectional views through various
regions of the cushion assembly 250. For example, Fig. 3-23 is a cross-sectional view
through the nose ridge region 252 and the top lip region 255 showing the single layer
or membrane 260 only structure in the nose ridge region 252 and the dual layer or
membrane 260 and undercushion 265 structure in the top lip region 255. Fig. 3-23
also shows the thinner cross-section area 268 in the side wall region 257 adjacent the
top lip region 255, e.g., to avoid excessive pressure on the columella or septum. In
addition, Fig. 3-23 shows the attachment region 258 including thinner wall section
258(1), e.g., to permit decoupling of tube drag forces. Figs. 3-24 and 3-25 show the
single layer or membrane 260 only structure in the sides of the nose region 253. Figs.
3-26 and 3-27 also show the single layer or membrane 260 only structure in the sides
of the nose region 253 as well as at least part of the wing or sealing flap 270 that
protrudes from the edge of the membrane 260. Fig. 3-27 and 3-28 show at least part
of the headgear connector 256. Figs. 3-29 and 3-30 show the dual layer or membrane
260 and undercushion 265 structure in the corners of nose region 254 and the top lip
region 255. Fig. 3-30 shows the thinner cross-section area 268 in the side wall region
257 adjacent the top lip region 255.
9.3.4 Positioning and stabilising structure 3300
In an example, the seal-forming portion 3100 of the patient interface 3000 of the
present technology is held in sealing position in use by the positioning and stabilising
structure 3300.
In one form, the seal-forming portion 3100 of the patient interface 3000 of the
present technology is held in sealing position via a two-point connection to a
positioning and stabilising structure 3300.
In one form, the positioning and stabilising structure 3300 connects to plenum
chamber 3200 via headgear connector 156.
In an example, there are only two connectors 156 to the plenum chamber 3200.
9.3.4.1 Headgear Connector
Headgear connector 156 may comprise a lug or interface 159 adapted to
receive a cushion connector 116 on headgear 110. A similar arrangement is disclosed
in PCT application number , filed 22 October 2008, which is
incorporated herein by reference in its entirety.
Headgear connectors 156 may be positioned at an angle relative to the vertical
axis of the seal region 151. As best shown in Figs. 3-6 and 3-7, headgear connectors
156 may be positioned at angle α relative to the vertical axis of the seal region 151. In
an example, angle α may be approximately 90-135°. In an example, angle α may be
approximately 90-120°. In an example, angle α may be approximately 90-100°. Angle
α aligns the headgear connectors in such a way so as to ensure a sealing force between
the cushion and the patient is sufficient to effect a seal without causing discomfort or
causing the cushion to collapse (for example, the closer angle α is to 180°, the more
likely the cushion is to collapse inwardly towards the vertical axis when headgear
tension is applied, thus pinching the patient’s nose), particularly in the sides of the
nose region 153 of sealing region 151.
In an alternative example, as best shown in Figs. 31, 33, 35, 3
6, 31, 33, 35, 36, a hinge or thinner wall section 356(1), 456(1) may
be provided to each headgear connector 356, 456 to enhance flexibility of the
headgear connectors and allow sufficient bending in use so headgear tensioning force
is not transferred to collapse the cushion inwardly, e.g., to avoid pinching of the alar
under headgear tension. Also, as shown in Fig. 36, one or more wall sections
457(1) of the side wall region 457 between the lugs of the headgear connectors may
be thickened, e.g., to prevent or reduce collapse of the side wall region under
headgear tension.
Headgear connectors 156 may be positioned at an angle relative to the
horizontal axis of the seal region 151. As best shown in Fig. 3-9, headgear connectors
156 may be positioned at angle β relative to the horizontal axis of the seal region 151.
In an example, angle β may be approximately 90-135°. In an example, angle β may be
approximately 90-120°. In an example, angle β may be approximately 90-100°. Angle
β aligns the headgear connectors in such a way so as to ensure the sealing force
provided by the headgear connectors 156 is distributed over the sealing region 151,
with more force provided in the top lip region 155 and corners of the nose region 154,
and less force provided in the nose ridge region 152. Such distribution may be more
comfortable and stable.
As shown in Fig. 3-8, headgear connectors 156 may have a first width w at a
region proximal to the side wall 157, and a second width w at its extremity, with first
width w being greater than second width w . In an example, first width w may be
1 2 1
about 15-50mm. In an example, first width w may be about 15-30mm. In an example,
first width w may be about 20-25mm. In an example, second width w may be about
-30mm. In an example, second width w may be about 15-25mm. In an example,
second width w may be about 15-20mm. First width w ensures that the force
provided by the headgear is spread from the sides of the nose region 153 to the
corners of the nose region 154, and also stabilizes the cushion in the horizontal plane.
Second width w is arranged to reduce the visual bulk of the headgear connector 156
and permit connection with cushion connector 116.
Headgear connectors 156 are advantageously disposed proximal to the sealing
region 151. Headgear connectors 156 are positioned at a height H from the sealing
region 151, as shown on Fig. 3-6. In an example, height H may be approximately 10-
50mm. In an example, height H may be approximately 10-30mm. In an example,
height H may be approximately 10-20mm. In an example, height H may be
approximately 20-30mm. This arrangement ensures that headgear forces are
translated directly to the sealing portion, and the sealing region is able to wrap or
conform to the patient’s nasal geometry.
The position and size of the headgear connectors directs the sealing force to
the sealing region in such a way so as to negate or eliminate the need for a forehead
support or vertical headgear strap. For example, the width of the headgear connectors
proximal to the side wall stabilizes the sealing region on the patient’s face. The height
of the headgear connectors 156 to the sealing region 151 ensures that headgear forces
are translated directly to the sealing portion, thereby eliminating the need for
additional stabilization from a forehead support.
In an alternative form of the present technology, headgear connectors 156 are
formed separately from the plenum chamber.
9.3.4.2 Headgear Assembly
One form of positioning and stabilising structure 3300 in accordance with the
present technology is headgear assembly 110. Headgear assembly 110 may be
adapted to support, stabilize and/or position the cushion assembly 150 on the patient’s
face.
As shown in Figs. 3-1 to 3-3, headgear assembly 110 may comprise a pair of
side straps 115, connected to a rear strap 118. Side straps 115 define a main headgear
loop that may be positioned along the sides of the patient’s face, across the patient’s
cheeks, extending between the eyes and the ears of the patient, e.g., overlaying at least
a portion of the zygomatic bone, towards the crown of the patient’s head where it e.g.,
overlays a portion of the parietal bone. Side straps 115 may have a cushion connector
116 adapted to receive a headgear connector 156 of cushion 150. Side straps 115 may
have an adjustment portion 117, wherein side straps 115 interlock or otherwise
connect to each other and are able to adjust in length relative to one another. Rear
strap 118 extends between the side straps and may loop through a respective slot 114
provided to the side straps 115. Rear strap 118 defines a rear headgear loop that may
be positioned over the back of the patient’s head, e.g., engaging along or below the
patient’s occiput. In an example, a portion of the headgear rear strap 118 or rear
headgear loop overlays or engages a point on the head below or inferior to the
occipital bone, e.g. a portion of the strap lies on a portion of the trapezius muscle,
adjacent the occipital bone in use. In an example, at least a portion of the rear strap
118 engages below or inferior a lower edge of the occipital bone, which lower edge
helps to maintain the rear strap in position and prevent the rear strap from riding up
the patient’s head, e.g., prevent sliding in a superior direction. Refer to Figs. 2i and 3-
2 for location of the trapezius and an exemplary positioning of the rear strap 118
along a portion of the trapezius. In an example, the headgear straps are sufficiently
stretchy or flexible, e.g., to enhance comfort and adjustability. For example, the
headgear may not require length adjustment to don.
In one form, headgear assembly 110 comprises a silicone main portion and a
fabric rear portion. In another form, headgear assembly 110 comprises a fabric main
portion and a fabric rear portion. In another form, headgear assembly 110 comprises a
silicone main portion and a silicone rear portion.
In one form, headgear assembly 110 is constructed and arranged to be
substantially floppy.
In one form, headgear assembly 110 comprises a main structural tie, and a rear
structural tie.
An exemplary headgear assembly 110 is disclosed in PCT application number
, filed 22 October 2008, which is incorporated herein by
reference in its entirety.
9.3.5 Vent 3400
In one form, the patient interface 3000 includes a vent 3400 constructed and
arranged to allow for the washout of exhaled carbon dioxide.
One form of vent 3400 in accordance with the present technology comprises a
plurality of holes, for example, about 20 to about 80 holes, or about 40 to about 60
holes, or about 45 to about 55 holes.
In an example, the vent 3400 is located in a decoupling structure 3500, e.g. a
swivel 3510. Alternatively, the vent 3400 is located in the plenum chamber 3200.
One form of vent 3400 in accordance with the present technology is vent 126.
Vent 126 may permit to expiration of exhaled gases from the nasal mask system. Vent
126 may comprise a series of holes, a mesh or other arrangement adapted to permit
the flow of gas. In an example, vent 126 may be sufficiently rigid to avoid collapse of
the air channels that exhaust the exhaled gas. Vent 126 may be positioned on the
elbow 125 or other region such as the air delivery tube assembly 130 or cushion
assembly 150 (including, for example, side wall 157).
In certain forms of the present technology, the vent 3400 may be constructed
from a flexible, or floppy material that is supported by a sufficiently rigid frame to
avoid collapse of the air channels that exhaust the exhaled gas.
In an alternative form, the patient interface 3000 does not include a vent.
9.3.6 Decoupling structure(s) 3500
In one form the patient interface 3000 includes at least one decoupling structure
3500, for example a swivel 3510 or a ball and socket 3520 (e.g., see Fig. 3-13). In one
form, decoupling structure 3500 may be formed at least in part by attachment region
158.
9.3.6.1 Attachment Region
Attachment region 158 may be adapted to receive elbow assembly 120.
Attachment region 158 may include a thinner wall section 158(1) than the side wall
region 157, for example attachment region 158 may have a wall section of about 0.1-
1mm, for example about 0.2-0.8mm, for example about 0.5mm. In an example, the
thinner wall section is configured to permit decoupling of the tube drag forces from
the sealing forces.
9.3.7 Connection port 3600
In one form, connection port 3600 to air circuit 4170 is made by elbow
assembly 120 (e.g., see Figs. 3-1 and 3-2).
9.3.7.1 Elbow Assembly
Elbow assembly 120 may be adapted to connect or serve as an interface
between the cushion assembly 150 and the air delivery assembly 130. Elbow
assembly 120 may be formed with or integral with the air delivery assembly 130, or
cushion assembly 150. Elbow assembly 120 may also be adapted to permit exhaust of
exhaled gases.
As shown in Figs. 3-1 to 3-3 and 3-11 to 3-13, elbow assembly 120 may
comprise an elbow 125, the elbow having a vent 126, the elbow connecting to or
otherwise formed with connector ring 128. Elbow 125 may be formed with a ball joint
and the connector ring 128 may for constructed and arranged to permit rotation of the
ball joint while ensuring a sufficient seal with the elbow to ensure air leakage does not
compromise the patient’s treatment pressure. The ball joint provides a decoupling
mechanism, e.g., decouple tube drag forces from sealing forces.
Elbow 125 may also be attached to or otherwise connected with swivel 129,
adapted to receive an air delivery tube assembly 130. Swivel 129 may be arranged
such that it may form a seal or have a low leak with elbow 125, while still being able
to freely rotate relative to elbow 125.
9.3.8 Forehead support
In an example, the patient interface 3000 does not include a forehead support,
however in one alternative form, a forehead support may be included.
9.3.9 Anti-asphyxia
In one form, the patient interface 3000 includes an anti-asphyxia valve.
9.3.10 Ports
In one form of the present technology, a patient interface 3000 includes one or more
ports, that allow access to the volume within the plenum chamber 3200. In one form
this allows a clinician to supply supplemental oxygen. In one form this allows for the
direct measurement of a property gases within the plenum chamber 3200, such as the
pressure.
9.3.11 Air circuit 4170
An air circuit 4170 in accordance with one form of the present technology is
air delivery assembly 130. Air delivery assembly 130 may be constructed to connect a
flow generator to mask system 100. As shown in Figs. 3-1 to 3-3, air delivery system
130 may comprise a tube 133 and a connector 135. Tube 133 may be relatively
flexible. Connector 135 may be adapted to receive swivel 129 of elbow assembly 120.
9.3.12 Donning and Removing
The nasal mask system provides a small, unobtrusive mask system that is easy
to don, easy to remove, is stable, comfortable, effective, provides wide-fit range,
unobtrusive, easy to use, and adjustable. In addition, the nasal mask system provides
a non-prong or non-pillows arrangement (i.e., nasal mask system provides nasal-type
cushion that provides single orifice adapted to surround both nares in use) that does
not suffer from problems of jetting effect, nor the potential discomfort associated with
nasal prongs or pillows adapted to at least partially extend up the patient’s nose. The
nasal mask system is structured such that little or no adjustment may be needed to fit
the nasal mask system to the patient's head. In an example, no forehead support is
provided to the mask system, though one can be provided if desired.
In the illustrated example, the nasal mask system 100 provides a two-point
connection with the cushion, i.e., two side straps 115 of the headgear assembly
engage respective headgear connector 156 along side of the cushion 150 (e.g., see
Figs. 3-1 to 3-3). The headgear assembly provides three adjustment points, e.g.,
adjustable portion 117 of the side straps 115 and respective adjustability of ends of the
rear strap 118 with a respective slot 114 of the side straps 115. However, it should be
appreciated that more or fewer adjustment points may be provided, e.g., side straps
and rear strap may provide fixed length with no adjustability.
In an example, the two-point connection does not does not require engagement
or disengagement of a clip in order to don or remove the mask system, i.e., no clips
are provided to the mask system but they can be provided if desired. Also, the main
headgear loop defined by the side straps 115 extends from an inferior anterior position
to a superior posterior position, which avoids any headgear strap extending below the
ears (i.e., straps do not pass inferior to the patient’s ear) as described below.
Figs. 3-31 to 3-34 provide a sequence of views to illustrate an exemplary
method for fitting the nasal mask system to a patient, e.g. prior to the application of
air pressure to the plenum chamber. As shown in Fig. 3-31, the patient may grasp the
nasal mask system such that one hand holds the cushion assembly 150 in a manner to
orient the sealing region towards the patient’s face and the other hand holds the rear
strap 118 in a manner to allow the main headgear loop defined by the side straps 115
to receive the patient’s head. Then, as shown in Fig. 3-32, the cushion assembly is
engaged with the patient’s face, and the rear strap is held over the patient’s head as it
passes through the main headgear loop. The rear strap, along with the side straps
attached thereto, may be pulled onto the patient’s head until the rear strap is
positioned along the back of the patient’s head as shown in Fig. 3-33, i.e., straps
rotated or pivoted about the cushion assembly onto the patient’s head until the straps
engage and self-locate onto the patient’s head. Finally, as shown in Fig. 3-34, ends of
the rear strap 118 and/or the adjustment portion 117 of the side straps may be adjusted
as necessary to secure the nasal mask system on the patient's head.
This arrangement is simple to put on and take off as the straps do not have to
be pulled down over the ears to don the mask system or pulled up over the ears to
remove the mask system, i.e., headgear straps easily slid on/off over the patient’s head
like a cap. That is, the mask system includes headgear that may be donned and
removed like a cap without interfering with the ears of the patient.
In use, the side straps 115 are arranged to pull the nasal mask system in a
superior posterior direction (e.g., as indicated by the arrow a1 in Fig. 3-34), which
provides less compressive force along the nose ridge region of the cushion assembly
150 which is advantageous as such region is along a more sensitive region of the
patient’s nose, i.e., along the cartilage of the nose (not bone) as described above.
Masks with nasal-type cushions normally include headgear arrangements arranged to
pull the mask along a direction that is substantially parallel to Frankfort horizontal (as
indicated by the arrow a2 in Fig. 3-34) so as to provide a compressive sealing force
substantially normal to the patient’s face. To provide such force, the headgear
arrangement includes straps that extend under the patient’s ears so as to provide such
force along the Frankfort horizontal direction. In the mask system according to an
example of the present technology, the headgear assembly is arranged to pull the
mask along the superior posterior direction, e.g., like an “under the nose” mask (e.g.,
pillows or cradle), which provides less compressive force along the nose ridge region
while maintaining sufficient seal as noted above. Thus, the nasal mask system
provides headgear that provides an effective sealing vector similar to “under the nose”
masks (i.e., not parallel to Frankfort horizontal), but instead used for mask that covers
part of the nose, i.e., the nasal mask system compromises sealing force strictly along
the Frankfort horizontal for an over the ear headgear arrangement to facilitate
donning.
9.3.13 Pivoting adjustment of plenum chamber
Fig. 3-9 shows a perpendicular distance h between a headgear connection
point hp, i.e., line of headgear tension as headgear connects to the cushion assembly
150, and a pivoting point or rotation axis pp of the cushion assembly 150 on the face,
i.e., the top lip. This perpendicular distance h allows adjustment of the headgear
tension to effect rotational or pivotal adjustment of the plenum chamber/cushion
assembly about the pivoting point pp. As illustrated, the headgear connection point hp
is superior to the pivoting point pp or point of contact of the cushion assembly with
the top lip. This arrangement enables a user to rotate/pivot the cushion assembly via
adjustment of headgear tension and to use only a two point headgear connection to
accommodate different nose ridge geometry. In an example, increasing the
perpendicular distance h will increase the moment.
9.4 PAP DEVICE 4000
A PAP device 4000 in accordance with one aspect of the present technology
comprises mechanical and pneumatic components, electrical components and is
programmed to execute one or more algorithms. In an example, PAP device has an
external housing, e.g., formed in two parts, an upper portion 4012 of the external
housing, and a lower portion 4014 of the external housing. In alternative forms, the
external housing may include one or more panel(s) 4015. In an example, the PAP
device 4000 comprises a chassis 4016 that supports one or more internal components
of the PAP device 4000. In one form a pneumatic block is supported by, or formed as
part of the chassis 4016. The PAP device 4000 may include a handle 4018.
In an example, pneumatic path of the PAP device 4000 comprises an inlet air
filter 4112, an inlet muffler, a controllable source of air at positive pressure (e.g., a
blower 4142), and an outlet muffler. One or more pressure sensors and flow sensors
are included in the pneumatic path.
In an example, pneumatic block comprises a portion of the pneumatic path
that is located within the external housing.
In an example, the PAP device 4000 has an electrical power supply 4210, one
or more input devices 4220, a processor, a pressure device controller, one or more
protection circuits, memory, transducers, data communication interface and one or
more output devices. Electrical components may be mounted on a single Printed
Circuit Board Assembly (PCBA) 4202. In an alternative form, the PAP device 4000
may include more than one PCBA 4202.
The processor of the PAP device 4000 is programmed to execute a series of
algorithm modules in use, e.g., including pre-processing transducer signals module, a
therapy engine module, a pressure control module, and further e.g., a fault condition
module.
9.5 GLOSSARY
In certain forms of the present technology, one or more of the following
definitions may apply. In other forms of the present technology, alternative definitions
may apply.
9.5.1 General
Air: Air will be taken to include breathable gases, for example air with
supplemental oxygen.
Positive Airway Pressure (PAP): PAP treatment will be taken to mean the
application of a supply of air or breathable gas to the entrance to the airways at a
pressure that is positive with respect to atmosphere. In one form, the pressure will be
continuously positive (CPAP) and e.g., approximately constant through a respiratory
cycle of a patient. In some forms, the pressure at the entrance to the airways will vary
by a few centimeters of water within a single respiratory cycle, for example being
higher during inhalation and lower during exhalation. In some forms, the pressure at
the entrance to the airways will be slightly higher during exhalation, and slightly
lower during inhalation. In some forms the pressure will be a number of centimeters,
e.g. about 5-15 cm of water pressure higher during inhalation than exhalation, and
provide ventilatory support. In some forms, the pressure will vary between different
respiratory cycles of the patient, for example being increased in response to detection
of indications of partial upper airway obstruction, and decreased in the absence of
indications of partial upper airway obstruction.
9.5.2 Anatomy of the face
Ala: the external outer wall or "wing" of each nostril (plural: alar)
Alare: The most lateral point on the nasal ala.
Alar curvature (or alar crest) point: The most posterior point in the curved base
line of each ala, found in the crease formed by the union of the ala with the cheek.
Auricula or Pinna: The whole external visible part of the ear.
(nose) Bony framework: The bony framework of the nose comprises e.g. the
nasal bones, the frontal process of the maxillae and the nasal part of the frontal bone.
(nose) Cartilaginous framework: The cartilaginous framework of the nose
comprises, e.g., the septal, lateral, major and minor cartilages.
Columella: the strip of skin that separates the nares and which runs from the
pronasale to the upper lip.
Columella angle: The angle between the line drawn through the midpoint of the
nostril aperture and a line drawn perpendicular to the Frankfurt horizontal while
intersecting subnasale.
Frankfort horizontal plane: A line extending from the most inferior point of the
orbital margin to the left tragion.
Glabella: Located on the soft tissue, the most prominent point in the midsagittal
plane of the forehead.
Lateral nasal cartilage: A generally triangular plate of cartilage. Its superior
margin is attached to the nasal bone and frontal process of the maxilla, and its inferior
margin is connected to the greater alar cartilage.
Greater alar cartilage: A plate of cartilage lying below the lateral nasal
cartilage. It is curved around the anterior part of the naris. Its posterior end is
connected to the frontal process of the maxilla by a tough fibrous membrane
containing three or four minor cartilages of the ala.
Nares (Nostrils): Approximately ellipsoidal apertures forming the entrance to
the nasal cavity. The singular form of nares is naris (nostril). The nares are separated
by the nasal septum.
Naso-labial sulcus or Naso-labial fold: The skin fold or groove that runs from
each side of the nose to the corners of the mouth, separating the cheeks from the
upper lip.
Naso-labial angle: The angle between the columella and the upper lip, while
intersecting subnasale.
Otobasion inferior: The lowest point of attachment of the auricle to the skin of
the face.
Otobasion superior: The highest point of attachment of the auricle to the skin of
the face.
Pronasale: the most protruded point or tip of the nose, which can be identified
in lateral view of the rest of the portion of the head.
Philtrum: the midline groove that runs from lower border of the nasal septum to
the top of the lip in the upper lip region.
Pogonion: Located on the soft tissue, the most anterior midpoint of the chin.
Ridge (nasal): The nasal ridge is the midline prominence of the nose, extending
from the Sellion to the Pronasale.
Sagittal plane: A vertical plane that passes from anterior (front) to posterior
(rear) dividing the body into right and left halves.
Sellion: Located on the soft tissue, the most concave point overlying the area of
the frontonasal suture.
Septal cartilage (nasal): The nasal septal cartilage forms part of the septum and
divides the front part of the nasal cavity.
Subalare: The point at the lower margin of the alar base, where the alar base
joins with the skin of the superior (upper) lip.
Subnasal point: Located on the soft tissue, the point at which the columella
merges with the upper lip in the midsagittal plane.
Supramentale: The point of greatest concavity in the midline of the lower lip
between labrale inferius and soft tissue pogonion
9.5.3 Anatomy of the skull
Frontal bone: The frontal bone includes a large vertical portion, the squama
frontalis, corresponding to the region known as the forehead.
Mandible: The mandible forms the lower jaw. The mental protuberance is the
bony protuberance of the jaw that forms the chin.
Maxilla: The maxilla forms the upper jaw and is located above the mandible and
below the orbits. The frontal process of the maxilla projects upwards by the side of
the nose, and forms part of its lateral boundary.
Nasal bones: The nasal bones are two small oblong bones, varying in size and
form in different individuals; they are placed side by side at the middle and upper part
of the face, and form, by their junction, the "bridge" of the nose.
Nasion: The intersection of the frontal bone and the two nasal bones, a
depressed area directly between the eyes and superior to the bridge of the nose.
Occipital bone: The occipital bone is situated at the back and lower part of the
cranium. It includes an oval aperture, the foramen magnum, through which the cranial
cavity communicates with the vertebral canal. The curved plate behind the foramen
magnum is the squama occipitalis.
Orbit: The bony cavity in the skull to contain the eyeball.
Parietal bones: The parietal bones are the bones that, when joined together,
form the roof and sides of the cranium.
Temporal bones: The temporal bones are situated on the bases and sides of the
skull, and support that part of the face known as the temple.
Zygomatic bones: The face includes two zygomatic bones, located in the upper
and lateral parts of the face and forming the prominence of the cheek.
9.5.4 Anatomy of the respiratory system
Diaphragm: A sheet of muscle that extends across the bottom of the rib cage.
The diaphragm separates the thoracic cavity, containing the heart, lungs and ribs,
from the abdominal cavity. As the diaphragm contracts the volume of the thoracic
cavity increases and air is drawn into the lungs.
Larynx: The larynx, or voice box houses the vocal folds and connects the
inferior part of the pharynx (hypopharynx) with the trachea.
Lungs: The organs of respiration in humans. The conducting zone of the lungs
contains the trachea, the bronchi, the bronchioles, and the terminal bronchioles. The
respiratory zone contains the respiratory bronchioles, the alveolar ducts, and the
alveoli.
Nasal cavity: The nasal cavity (or nasal fossa) is a large air filled space above
and behind the nose in the middle of the face. The nasal cavity is divided in two by a
vertical fin called the nasal septum. On the sides of the nasal cavity are three
horizontal outgrowths called nasal conchae (singular "concha") or turbinates. To the
front of the nasal cavity is the nose, while the back blends, via the choanae, into the
nasopharynx.
Pharynx: The part of the throat situated immediately inferior to (below) the
nasal cavity, and superior to the oesophagus and larynx. The pharynx is
conventionally divided into three sections: the nasopharynx (epipharynx) (the nasal
part of the pharynx), the oropharynx (mesopharynx) (the oral part of the pharynx),
and the laryngopharynx (hypopharynx).
9.5.5 Materials
Silicone or Silicone Elastomer: A synthetic rubber. In this specification, a
reference to silicone is a reference to liquid silicone rubber (LSR) or a compression
moulded silicone rubber (CMSR). One form of commercially available LSR is
SILASTIC (included in the range of products sold under this trademark),
manufactured by Dow Corning. Another manufacturer of LSR is Wacker. Unless
otherwise specified to the contrary, an exemplary form of LSR has a Shore A (or
Type A) indentation hardness in the range of about 35 to about 45 as measured using
ASTM D2240.
9.5.6 Aspects of a patient interface
Anti-asphyxia valve (AAV): The component or sub-assembly of a mask system
that, by opening to atmosphere in a failsafe manner, reduces the risk of excessive CO
rebreathing by a patient.
Elbow: A conduit that directs an axis of flow or air to change direction through
an angle. In one form, the angle may be approximately 90 degrees. In another form,
the angle may be less than 90 degrees. The conduit may have an approximately
circular cross-section. In another form the conduit may have an oval or rectangular
cross-section.
Frame: Frame will be taken to mean a mask structure that bears the load of
tension between two or more points of connection with a headgear. A mask frame
may be a non-airtight load bearing structure in the mask. However, some forms of
mask frame may also be air-tight.
Headgear: Headgear will be taken to mean a form of positioning and stabilizing
structure designed for use on a head. In an example, the headgear comprises a
collection of one or more struts, ties and stiffeners configured to locate and retain a
patient interface in position on a patient’s face for delivery of respiratory therapy.
Some ties are formed of a soft, flexible, elastic material such as a laminated composite
of foam and fabric.
Membrane: Membrane, e.g., in the context of a sealing portion and/or face-
contacting portion, will be taken to mean a typically thin element that has, e.g.,
substantially no resistance to bending, but has resistance to being stretched.
Plenum chamber: a mask plenum chamber will be taken to a mean portion of a
patient interface having walls enclosing a volume of space, the volume having air
therein pressurised above atmospheric pressure in use. A shell may form part of the
walls of a mask plenum chamber. In one form, a region of the patient's face forms one
of the walls of the plenum chamber.
Seal: The noun form ("a seal") will be taken to mean a structure or barrier that
intentionally resists the flow of air through the interface of two surfaces. The verb
form ("to seal") will be taken to mean to resist a flow of air.
Shell: In an example, a shell will be taken to mean a curved structure having
bending, tensile and compressive stiffness, for example, a portion of a mask that
forms a curved structural wall of the mask. In an example, compared to its overall
dimensions it is relatively thin. In some forms, a shell may be faceted. In an example,
such walls are airtight, although in some forms they may not be airtight.
Stiffener: A stiffener will be taken to mean a structural component designed to
increase the bending resistance of another component in at least one direction.
Strut: A strut will be taken to be a structural component designed to increase the
compression resistance of another component in at least one direction.
Swivel: (noun) A subassembly of components configured to rotate about a
common axis, e.g., independently, e.g., under low torque. In one form, the swivel may
be constructed to rotate through an angle of at least 360 degrees. In another form, the
swivel may be constructed to rotate through an angle less than 360 degrees. When
used in the context of an air delivery conduit, the sub-assembly of components, e.g.,
comprises a matched pair of cylindrical conduits. Preferably there is little or no leak
flow of air from the swivel in use.
Tie: A tie will be taken to be a structural component designed to resist tension.
Vent: (noun) the structure that allows a deliberate controlled rate leak of air
from an interior of the mask, or conduit to ambient air, to allow washout of exhaled
carbon dioxide (CO ) and supply of oxygen (O ).
9.5.7 Terms used in relation to patient interface
Floppy: A quality of a material, structure or composite that is the combination
of features of:
Readily conforming to finger pressure.
Unable to retain its shape when caused to support its own weight.
Not rigid.
The quality of being floppy may have an associated direction, hence a particular
material, structure or composite may be floppy in a first direction, but stiff or rigid in
a second direction, for example a second direction that is orthogonal to the first
direction.
Resilient: Able to deform substantially elastically, and to release substantially all
of the energy upon unloading, within a relatively short period of time such as 1
second.
Rigid: Not readily deforming to finger pressure, and/or the tensions or loads
typically encountered when setting up and maintaining a patient interface in sealing
relationship with an entrance to a patient's airways.
Semi-rigid: means being sufficiently rigid to not substantially distort under the
effects of mechanical forces typically applied during positive airway pressure therapy.
9.6 OTHER REMARKS
A portion of the disclosure of this patent document contains material which is
subject to copyright protection. The copyright owner has no objection to the facsimile
reproduction by anyone of the patent document or the patent disclosure, as it appears
in the Patent and Trademark Office patent file or records, but otherwise reserves all
copyright rights whatsoever.
Unless the context clearly dictates otherwise and where a range of values is
provided, it is understood that each intervening value, to the tenth of the unit of the
lower limit, between the upper and lower limit of that range, and any other stated or
intervening value in that stated range is encompassed within the technology. The
upper and lower limits of these intervening ranges, which may be independently
included in the intervening ranges, are also encompassed within the technology,
subject to any specifically excluded limit in the stated range. Where the stated range
includes one or both of the limits, ranges excluding either or both of those included
limits are also included in the technology.
Furthermore, where a value or values are stated herein as being implemented as
part of the technology, it is understood that such values may be approximated, unless
otherwise stated, and such values may be utilized to any suitable significant digit to
the extent that a practical technical implementation may permit or require it.
Unless defined otherwise, all technical and scientific terms used herein have the
same meaning as commonly understood by one of ordinary skill in the art to which
this technology belongs. Although any methods and materials similar or equivalent to
those described herein can also be used in the practice or testing of the present
technology, a limited number of the exemplary methods and materials are described
herein.
When a particular material is identified as being preferably used or as being an
example to construct a component, obvious alternative materials with similar
properties may be used as a substitute.
It must be noted that as used herein and in the appended claims, the singular
forms "a", "an", and "the" include their plural equivalents, unless the context clearly
dictates otherwise.
All publications mentioned herein are incorporated by reference to disclose and
describe the methods and/or materials which are the subject of those publications. The
publications discussed herein are provided solely for their disclosure prior to the filing
date of the present application. Nothing herein is to be construed as an admission that
the present technology is not entitled to antedate such publication by virtue of prior
invention. Further, the dates of publication provided may be different from the actual
publication dates, which may need to be independently confirmed.
Moreover, in interpreting the disclosure, all terms should be interpreted in the
broadest reasonable manner consistent with the context. In particular, the terms
"comprises" and "comprising" should be interpreted as referring to elements,
components, or steps in a non-exclusive manner, indicating that the referenced
elements, components, or steps may be present, or utilized, or combined with other
elements, components, or steps that are not expressly referenced.
The subject headings used in the detailed description are included only for the
ease of reference of the reader and should not be used to limit the subject matter found
throughout the disclosure or the claims. The subject headings should not be used in
construing the scope of the claims or the claim limitations.
Although the technology herein has been described with reference to particular
embodiments, it is to be understood that these embodiments are merely illustrative of
the principles and applications of the technology. In some instances, the terminology
and symbols may imply specific details that are not required to practice the
technology. For example, although the terms "first" and "second" may be used, unless
otherwise specified, they are not intended to indicate any order but may be utilised to
distinguish between distinct elements. Furthermore, although process steps in the
methodologies may be described or illustrated in an order, such an ordering is not
required. Those skilled in the art will recognize that such ordering may be modified
and/or aspects thereof may be conducted concurrently or even synchronously.
It is therefore to be understood that numerous modifications may be made to the
illustrative embodiments and that other arrangements may be devised without
departing from the spirit and scope of the technology.
Reference signs list
nasal mask system 100
headgear assembly 110
slot 114
side straps 115
cushion connector 116
adjustment portion 117
rear strap 118
elbow assembly 120
elbow 125
vent 126
connector ring 128
swivel 129
air delivery assembly 130
tube 133
connector 135
cushion assembly 150
sealing region or sealing cuff 151
nose ridge region 152
side of nose region 153
corner of nose region 154
top lip region 155
headgear connectors 156
side wall region or side wall 157
attachment region 158
thinner wall section 158(1)
lug 159
membrane 160
undercushion or backup band 165
cushion assembly 250
sealing region 251
nose ridge region 252
side of nose region 253
corner of nose region 254
top lip region 255
headgear connector 256
side wall region 257
thinner wall section 258(1)
attachment region 258
membrane 260
undercushion or backup band 265
area of thinner cross-section 268
sealing flap or wing 270
orifice 275
upper orifice portion 275(1)
lower orifice portion 275(2)
contact area 280
inner edge 280(i)
outer edge 280(o)
cushion assembly 350
hinge 356(1)
membrane 360
outer edge 360(o)
cushion assembly 450
hinge 456(1)
side wall region 457
wall section 457(1)
membrane 460
outer edge 460(o)
inner edge 460(i)
undercushion 465
sickle shaped cross-section 466
patient 1000
bed partner 1100
patient interface 3000
seal forming structure 3100
superior sealing portion 3102
inferior sealing portion 3104
sealing flange 3110
support flange 3120
plenum chamber 3200
perimeter 3210
marginal edge 3220
positioning and stabilising structure 3300
vent 3400
decoupling structure 3500
swivel 3510
socket 3520
connection port 3600
pap device 4000
upper portion 4012
lower portion 4014
panels 4015
chassis 4016
handle 4018
inlet air filter 4112
blower 4142
air circuit 4170
PCBA 4202
electrical power supply 4210
input devices 4220
humidifier 5000
Claims (9)
1. A nasal mask system, comprising: a cushion assembly including a sealing region having a nose ridge region, sides of nose region, corners of nose region, and a top lip region adapted to seal around both nares of a patient’s nose, the nose ridge region adapted to be positioned and seal along a nasal cartilage region which is above the pronasale and below a nasal bone region of the patient’s nasal bridge, and the sides of nose region adapted to extend across the alar or flares of the patient’s nose, the sealing region including a membrane seal that extends around an entire perimeter of the sealing region and an undercushion that is only provided in the top lip and corners of nose regions such that the sides of nose region includes a single layer or membrane only structure configured and arranged to seal along the alar or flares of the patient’s nose and prevent excess pressure on the alar or flares of the patient’s nose.
2. The nasal mask system according to claim 1, wherein the membrane and undercushion provide a compression seal in the top lip and corners of nose regions.
3. The nasal mask system according to claim 1, wherein the nose ridge and sides of the nose regions of the membrane are constructed and arranged to be in tension in use, and/or the membrane is constructed and arranged such that a pressure within a breathing chamber provided by the cushion assembly acts on the membrane to provide a seal.
4. The nasal mask system according to claim 1, wherein the sides of nose region includes a portion adapted to be positioned and seal substantially on the cartilaginous framework of the patient’s nose along a region adjacent the junction between the nasal greater alar cartilage and the lateral nasal cartilage of the patient’s nose.
5. The nasal mask system according to claim 4, wherein the portion includes a wing or sealing flap that protrudes from an edge of the membrane along its inner perimeter.
6. The nasal mask system according to claim 5, wherein the wing or sealing flap is at least partially angled outwardly away from a breathing chamber provided by the cushion assembly.
7. The nasal mask system according to claim 1, wherein the membrane has an edge that defines a T-shaped orifice.
8. The nasal mask system according to claim 1, wherein the nose ridge region includes at least a portion that is locally saddle-shaped in curvature.
9. The nasal mask system according to claim 1, wherein the top lip region includes at least a portion that is locally saddle-shaped in curvature.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ770002A NZ770002A (en) | 2011-11-15 | 2012-11-15 | Nasal mask system |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2011904754 | 2011-11-15 | ||
AU2011904754A AU2011904754A0 (en) | 2011-11-15 | Nasal Mask System | |
NZ73791812 | 2012-11-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
NZ754023A true NZ754023A (en) | 2020-12-18 |
NZ754023B2 NZ754023B2 (en) | 2021-03-19 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220176055A1 (en) | Nasal mask system | |
US20210338965A1 (en) | Nasal mask system | |
US20220379061A1 (en) | A therapy system for respiratory-related disorders, and patient interface and headgear for use in same | |
NZ754023A (en) | Nasal mask system | |
NZ624925B2 (en) | Nasal mask system | |
NZ754023B2 (en) | Nasal mask system | |
NZ720877B2 (en) | Nasal mask system | |
NZ760726B2 (en) | Nasal Mask System |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 6 YEARS UNTIL 15 NOV 2022 BY JAMES + WELLS Effective date: 20210506 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 NOV 2023 BY ANAQUA SERVICES Effective date: 20221022 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 NOV 2024 BY ANAQUA SERVICES Effective date: 20231020 |